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The design and development of “e-Vaccination” applications are not extensively researched 
within developing economies, in part because of the difficulty in gaining access to government 
officials and medical experts. Vaccination cards have been used to keep track of minors’ 
immunisation records in South Africa for over 30 years. The South African government is 
moving towards the use of electronic systems for the storage of such information.  
South Africa has a clearly defined electronic health strategy, which is to utilise information and 
communications technologies in healthcare to inter alia, engage in medical research, promote 
health education, monitoring of diseases and tracking public health. Supporting this strategy 
means digitising current paper-based systems. The result would be information that can be 
stored safely, backed up and analysed more easily than paper-based journals, documents 
and vaccination cards. 
The purpose of this research is to develop a better understanding of key stakeholders’ 
perceptions to the replacement of paper-based vaccination cards with an electronic system. 
This is important because digital records can be considered as a more effective method of 
storing vaccination data. 
This study is quantitative in nature and primary data in the form of Likert scale questionnaires 
were collected from 118 key stakeholders being nurses, doctors, parents and school 
administration staff. The Likert scale questionnaire data was analysed using the following 
statistical techniques: Cronbach Alpha Test, Chi-Square Test, Analysis of Variance Test and 
Principle Component Analysis. The analysis provided a deeper understanding of the key 
stakeholder’s perceptions to the use of e-Vaccination applications. 
e-Vaccination applications are affected by user friendliness of the application, the graphical 
design of the application, practicality of the application, user experience of the application as 
well as the usability of the application.  
The practical implications of this research on e-Vaccination applications is that designers, 
developers, policymakers and government have a deeper understanding of nurses, doctors, 
parents and school administration staff perceptions to the use of e-Vaccination. 
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CHAPTER 1: INTRODUCTION 
 
Figure 1.1: Structure of Chapter 1 
1.1 PURPOSE OF THE STUDY 
The purpose of this research is to review the current paper-based vaccination record 
management mechanism in Gauteng in order to determine whether this system should 
be digitised.  
“One of the best ways to protect your children is to make sure they have all of their 
vaccinations” (Department of Health, 2019b). A person is immunised against an 
infectious disease usually by being administered a vaccine. This process is called 
immunisation (WHO, 2019a). Immunisation of children in South Africa starts when 
they are born and the last vaccination is administered at 12 years of age (Department 
 2 
of Health, 2019b). In South Africa, the immunisation records of children are managed 
by a mixture of paper-based and electronic systems (van den Heever, 2012).  
Gauteng is the economic hub of South Africa (Stats SA, 2018b) with a population of 
around 13 399 724 (Stats SA, 2016). In Gauteng 528 922 households live in informal 
settlements (“Gauteng: Informal Settlements Status,” 2012). Informal settlements are 
susceptible to natural disasters such as flooding and heavy winds and are also prone 
to damage from fires. These disasters make physical documents such as vaccination 
cards susceptible to loss or damage. 
When a child’s immunisation card is lost or damaged, there is no immediate way to 
determine which diseases the child has been immunised against. This poses a 
challenge to parents as well as healthcare professionals when examining children for 
illnesses. Several countries have therefore implemented electronic vaccination record 
systems to manage these vital records. As part of this research, the vaccination record 
mechanisms of 16 countries will be investigated.  
1.2 CONTEXT OF THE STUDY 
Converting paper-based records into an electronic format in the healthcare sector has 
led to an increase in the quality of the data (Botha, 2015). In countries such as Estonia, 
95% of healthcare records have already been digitised (e-Estonia, 2016). This high 
rate of digitisation implies high data quality of healthcare records.  
South Africa’s eHealth strategy aims to utilise information in its digital form, together 
with the relevant ICTs as a medium and storage for the information, to monitor public 
health as well as to treat patients, according to the Department of Health (2012). In 
2017, Gauteng experienced a Measles outbreak (Mdhluli, 2017). Monitoring of the 
public’s health with accurate and up to date information, such as determining if children 
have been vaccinated against such a disease, can be critical during such outbreaks. 
South Africa is not ready for a national electronic health record (Kleynhans, 2011). 
This research does not provide a view on a national level but rather focuses on the 
Gauteng province in particular.  
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1.3 PROBLEM STATEMENT 
Countries in Europe and North America are moving towards Electronic Health Records 
as part of their eHealth Strategies (Kleynhans, 2011). In Gauteng, the immunisation 
record system is primarily paper-based and not yet fully automated as information still 
requires manual input from reports and not directly by the healthcare practitioner into 
digital systems (van den Heever, 2012). No South African Government based 
(Electronic Health Record) EHR system has been designed with the view of making 
children's immunisation records available to various stakeholders’ viz. parents, 
medical practitioners and the government itself.  
Systems that store vaccination records as a mixture of electronic systems and paper-
based records can result in inconsistences which can have an effect on vaccination 
statistics. 
The safe storage of physical documents such as vaccination cards is challenging in 
Gauteng due to a high number of households living in informal settlements. 
Vulnerabilities such as fire and flooding in these types of dwellings magnifies the risk 
of paper-based vaccination cards.  
During the outbreak of diseases such as the Gauteng Measles outbreak in 2017, as 
well as the recent Coronavirus disease (COVID-19) pandemic in 2020, paper-based 
records might not be sufficient in determining who is immunised against diseases and 
who is not.  
This calls for a better understanding of vaccination record systems in Gauteng, and 
the possible replacement of the current paper-based vaccination card with an 
electronic vaccination records system by understanding the perceptions of the key 
stakeholders who are involved with vaccination records. 
1.4 RESEARCH QUESTION 
The perception of converting the existing paper-based vaccination card system to an 
electronic vaccination records management system will be determined by responses 
to the research questionnaire from key stakeholders. The question this research aims 
to answer is: 
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“What are the perceptions of the key stakeholders towards replacing the paper-based 
vaccination card with an electronic vaccination record system?” 
1.5 SIGNIFICANCE OF THE STUDY 
The efficacy of electronic medical records and systems have been investigated in 
South Africa as well as other African countries such as Rwanda. The EMR 
implemented at the Ndera Hospital in Rwanda has had a positive outcome 
(Twizeyimana, 2016). There have been positive steps taken in South Africa that have 
led to securing the future of electronic health systems (Kleynhans, 2011).  
The health records that have been investigated so far by other authors have 
concentrated on records that are stored by healthcare facilities. The onus of the safe 
and secure storage of vaccination records currently resides with the child’s parents or 
guardians. Vaccination records were mentioned by Kleynhans (2011), as having the 
potential to be digitally stored but the semantics of converting from the paper-based 
system to an electronic one was not covered in-depth.  
Based on the advantages of digital health records such as better storage and back up, 
effective reporting and other downstream applications, this research then builds on 
the foundations that have already been laid by other authors and will add to it by taking 
these “client-facing” records and converting them into a digital format that can be 
utilised by government to achieve their eHealth strategic aims. 
1.6 DELIMITATIONS OF THE STUDY 
This research focusses on the Gauteng province within South Africa. Gauteng was 
chosen because it is the province with the largest population and population density 
in South Africa (South African Government, 2018). Gauteng is also the economic hub 
of South Africa and attracts the most amount of migrants from other provinces seeking 
employment (Stats SA, 2018b).  
The four groups of key stakeholders identified were parents, doctors, nurses and 
school administration staff. They were chosen due to their involvement with 
vaccinations and vaccination records. Other stakeholder types outside of these four 
groups were not considered. Respondents to the questionnaire were asked to select 
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their primary role as part of the research. If they embodied more than one stakeholder 
group, their secondary role was not considered. 
1.7 ASSUMPTIONS 
Assumptions made during the course of this research are: 
• Stakeholders who want to participate in the research questionnaire have 
access to the Internet when filling in the questionnaire; and 
• There is adequate Internet access at the healthcare facilities. 
1.8 RESEARCH OBJECTIVE 
The objective of this study is to understand the key stakeholders’ perceptions of an 
electronic vaccination record system as a means of keeping track of immunisation 
records in Gauteng. 
1.9 RATIONALE OF THE RESEARCH 
This research is motivated by both a scientific and personal rationale, as further 
detailed below. 
1.9.1 SCIENTIFIC RATIONALE 
The research field of e-Government is concerned with transforming manually intensive 
and paper-based processes at government level into an electronic format. The 
accuracy of data in an electronic format can be superior to data that is stored in purely 
paper-based or a hybrid paper-based and electronic system (Department of Health, 
2012). 
This research considers how EHR systems can improve the data quality and 
usefulness of immunisation records in Gauteng. 
1.9.2 PERSONAL RATIONALE 
The researcher is an Information Systems consultant who has extensive experience 
in the digitising of paper-based systems. When the researcher became a father in 
2014, he saw that the Department of Health still used paper-based vaccination cards. 
He soon embarked on an undertaking to determine whether an electronic based 
system would be more reliable and convenient to the various stakeholders in Gauteng. 
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1.10 ETHICAL CONSIDERATIONS 
The ethical considerations for this research took into account the data collection 
processes (the questionnaire) as well as the use of the prototype that was designed 
for this research. 
1.10.1 QUESTIONNAIRE 
No personal or identifiable information of the respondents to the questionnaire was 
collected or published in this research. Respondents were not forced to complete the 
questionnaire and could have opted-out from completing the questionnaire before the 
response was submitted electronically or prior to the physical copy being handed in.  
Ethical clearance has been received from the UNISA CAES department (Appendix 4). 
Permission was also received from the Ekurhuleni Health District Research 
Committee and the Tshwane Research Committee (Appendices 5 and 6). 
1.10.2 PROTOTYPE 
A generic login was created for the respondents, which ensured the anonymity of the 
respondents. No sensitive or personally identifiable information were required by the 
respondents.  
1.11 SUMMARY 
The subsequent six chapters in this dissertation are described in Figure 1.2.  
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Figure 1.2: List of Chapters 
The structure of the dissertation as outlined in Figure 1.2 is explained in greater detail 
below: 
• Chapter 2 (Literature Review) contains the investigation of various vaccination 
storage mechanisms globally as well as the eHealth aims of the Department of 
Health. 
• Chapter 3 (Research Methodology) details the data collection, sampling 
methods and statistical analysis techniques that were used in this research.  
• Chapter 4 (Artefact) is a detailed explanation of the prototype system (e-
Vaccination) that was developed as part of this research. It contains the overall 
design as well as the rationale behind the features that were included. 
• Chapter 5 (Presentation of results) presents the results and outcomes of the 
statistical analysis that was performed on the data that was collected. 
• Chapter 6 (Discussion of results) is an explanation and interpretation of the 
results of the statistical analysis in relation to the research topic and research 
question. 
 8 
• Chapter 7 (Conclusions and recommendations) concludes the research by 
outlining the outcomes of the research in relation to the digitisation of 
vaccination records. Recommendations for future research as well as 
recommendations for the future of vaccination records in Gauteng, South Africa 
are presented.  
In the next chapter (Literature Review), vaccination storage mechanisms will be 
discussed. The elements of the systematic literature review that was used in this 
research will also be discussed.  
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CHAPTER 2: LITERATURE REVIEW 
 
Figure 2.1: Structure of Chapter 2 
2.1 INTRODUCTION 
Elements of a systematic literature review approach involving a review of the current 
published materials (Remenyi, 2017) was followed during this research. Some of the 
systematic literature review steps as described by the University of Sydney (The 
University of Sydney, 2019) were followed. These steps, together with a summary of 
their outcomes, are listed in Figure 2.2. A detailed review of the investigations 
performed during the literature review along with the respective outcomes, for each 




Figure 2.2: A summary of the five steps taken to compile a literature review as outlined by the University 
of Sydney, (The University of Sydney, 2019), together with the outcomes of each step 
2.2 FORMULATION OF THE RESEARCH QUESTION AND ELIGIBILITY CRITERIA 
Steps one (Formulate the research question) and two (Develop eligibility criteria) took 
place in parallel due to a close linkage between the research question and the 
identification of the stakeholders (Figure 2.3). 
 
Figure 2.3: Steps 1 and 2 - Formulate the research question and develop the eligibility criteria 
Step Outcome (Summary) 
1. Formulate the 
research question 
What are the perceptions of the key stakeholders towards replacing the 




Location: Gauteng, South Africa 
Stakeholders: Parents, Doctors, Nurses, School Administration Staff 
Exclusions: Travel vaccines 
3. Search the 
literature 




Digital health strategies: Global and the Department of Health 
4. Screen the 
literature 
No less than 10 peer reviewed papers were screened to determine their 
relevance. From this, 4 vital concepts were identified 
The global digital health advances pertaining to immunisation records were 
filtered and focussed on the BRICS nations due to their relevance to South 
Africa 
5. Extract the data 
The level of progress regarding digital health systems pertaining to 




The accuracy of data in an electronic format can be superior to data that is stored 
purely paper-based or in a hybrid paper-based and electronic system (Department of 
Health, 2012). This research therefore needed to be more refined and led to the 
following question, “Could an electronic based system be used to manage vaccination 
records in Gauteng?” The investigation of electronic and paper-based systems 
therefore supported the scientific rationale. 
Use-Case models are used in software development for capturing and describing 
features of a system  (Anda, Dreiem, Sjøberg, & Jørgensen, 2001). Use cases were 
therefore used to determine the features of an electronic vaccination record system. 
Upon examination of the physical vaccination card, three potential use cases for an 
electronic based system were identified, that is, 
• Creating a vaccination record by a nurse or parent;  
• Viewing vaccination records by nurses, doctors and parents; and 
• Requesting vaccination records by school administration staff. 
These use cases indirectly determined the four key stakeholders involved with the 
physical vaccination card, these are: 
• Parents; 
• Nurses; 
• Doctors; and 
• School administration staff. 
Increasing stakeholder participation has become a key focus area in the improvement 
of digital systems such as decision support systems (Ingram & Gaskell, 2018). It was 
therefore vital to include the identified stakeholders in the research by understanding 
their perceptions towards managing vaccination records using a digital system.  
The inclusion of the key stakeholders in the research therefore led to further 
refinement of the research question, with the final research question being: “What are 
the perceptions of the key stakeholders towards replacing the paper-based 
vaccination card with an electronic vaccination record system?” 
During the refinement of the research question, parallel conclusions drawn in relation 
to the eligibility criteria became apparent. Gauteng was the province in which the 
researcher resided, and it is South Africa’s economic hub (Stats SA, 2018b) and the 
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destination for most of South Africa’s migrants (Stats SA, 2018b). Gauteng was 
therefore selected as the only province that the research would be conducted in and 
would be the geographical location of the research. To enhance the focus of the 
research, we decided to include only vaccination records pertaining to general child 
health (Department of Health, 2019a) within Gauteng. Vaccinations are also required 
when travelling to certain countries (Netcare, 2016) however, these vaccinations were 
excluded from this research. 
2.3 SEARCH AND SCREEN THE LITERATURE 
A search for relevant literature was conducted (Figure 2.4) to determine the extent of 
use of electronic health records in South Africa and globally. 
 
Figure 2.4: Step 3 - Search the literature 
Table 2.1 shows the digital sources that were searched together with the search terms 
used. The search terms were not necessarily used in each digital source. 
Table 2.1: Summary of the digital sources that were searched together with some of the search terms 
used 




• Electronic vaccination cards 
• Vaccination cards 
• Immunisation records 
• Electronic medical record 
• Electronic health records 
• South Africa and Medical records 
• eHealth 
 
The matrix in Table 2.2 was constructed based on the concept matrix demonstrated 
by Klopper & Lubbe (2011). The matrix illustrates the authors that were referenced 
during this research along with the key concepts that each author presented in their 
papers. 
Step Outcome (Summary) 
1. Formulate the 
research question 
What are the perceptions of the key stakeholders towards replacing the 
current paper-based vaccination card with e-Vaccination? 
2. Develop 
eligibility criteria 
Location: Gauteng, South Africa 
Stakeholders: Parents, Doctors, Nurses, School Administration Staff 
Exclusions: Travel vaccines 
3. Search the 
literature 




Digital health strategies: Global and the Department of Health 
4. Screen the 
literature 
No less than 10 peer reviewed papers were screened to determine their 
relevance. From this, 4 vital concepts were identified 
The global digital health advances pertaining to immunisation records were 
filtered and focussed on the BRICS nations due to their relevance to South 
Africa 
5. Extract the data 
The level of progress regarding digital health systems pertaining to 


















(Botha, 2015)  ü ü   
(Chachou et al., 2015)   ü ü 
(Sanftenberg et al., 2016)     ü 
(Chan et al., 2017)   ü   
(Ndirangu et al., 2009)    ü 
(Liu et al., 2017)  ü ü   
(Tozzi et al., 2016)   ü  ü 
(Westley et al., 2014)   ü  ü 
(LeardMann et al., 2007)   ü   
(Fontanesi et al., 2002)   ü ü  
(Nolen et al., 2018)  ü   
(Wang et al., 2015)  ü   
 
The concept matrix in Table 2.2 provides a holistic view of the key concepts that were 
identified by the referenced authors. It places emphasis on or grouping by concepts 
rather than emphasis on or grouping by the authors (Klopper & Lubbe, 2011). These 
key concepts influenced the focus of this literature review and were incorporated into 
e-Vaccination and the research questionnaire. The literature was then screened to 
assess its relevance in relation to the use of electronic health records in Gauteng 
(Figure 2.5).  
 
Figure 2.5: Step 4 – Screen the literature 
Countries are increasingly moving towards electronic health records (Botha, 2015; 
Kleynhans, 2011) as part of their eHealth strategies.  
The literature review therefore explored this trend in other countries, with particular 
emphasis on the storage of vaccination records. To ensure that a range of 
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comparisons regarding the storage of vaccination records was used, the literature 
review included an analysis of 16 countries, spread across all of the inhabited 
continents, to form a global picture. The countries were also selected based on their 
country classification as either developed, developing or countries in transition (United 
Nations, 2014). Of these 16 countries, the BRICS nations were further subjected to 
more in-depth research, in light of South Africa having joined these nations in 
December 2010 (About BRICS, 2017), and as a result of to their similarity and 
cooperation with South Africa in terms of economics, health, science and technology 
(About BRICS, 2017). 
Digital health systems pertaining to immunisation records within the BRICS nations 
were therefore investigated with particular emphasis. Table 2.3 illustrates the 
classification (developed, developing or countries in transition), geographical location 
(Africa, North America, South America, Europe, Asia or Australia) and BRICS 
association of the 16 countries that were researched. For the purposes of this 
research, Russia is considered to be part of Asia and not Europe. 



































































































Brazil   ü  ü     ü 
Russia  ü     ü   ü 
India   ü       ü 
China   ü    ü   ü 
South Africa   ü     ü  ü 
Estonia ü     ü     
Norway ü     ü     
The Netherlands ü     ü     
Australia ü        ü  
New Zealand ü        ü  
Sierra Leone   ü     ü   
Tanzania   ü     ü   
Mongolia   ü    ü    
Vietnam   ü    ü    
New Mexico   ü ü       
Uruguay   ü  ü      
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Upon tallying the numbers in each category, the representation is as follows: 
Developed Countries: 5; Economies in Transition: 1; Developing Countries: 10; North 
America: 1; South America: 2; Europe: 3; Asia: 4; Africa: 3; Australia/Oceania: 2; and 
BRICS: 5.  
The peer reviewed papers revealed that countries have become less reliant on 
paper-based systems as a result of the large-scale conversion of paper-based records 
to digital records (Botha, 2015).  
When reviewing the literature in relation to South Africa, it was found that measures 
are being taken to create an Electronic Health Record in South Africa (Kleynhans, 
2011) and that immunisation is a type of clinical data relating to patient care in South 
Africa (Botha, 2015). Neither of these studies however, placed specific emphasis on 
how vaccination records could be digitised within Gauteng. In addition, it was found 
that no South African Government-based electronic health system had been designed 
with the view to making minors’ vaccination records easily available to the identified 
stakeholder groups viz. parents, doctors, nurses and school administration staff. 
Upon further investigation, it was confirmed that in Gauteng, the immunisation record 
system is primarily paper-based and not yet fully automated (van den Heever, 2012). 
This called for a better understanding of vaccination record systems in Gauteng and 
a possible replacement of the current paper-based vaccination card with an electronic 
vaccination record system.  
These literature findings supported the relevance of this research, as the research 
focuses on both the conversion of the paper-based vaccination card into a digital 
record and making it accessible to the various stakeholders.  




Figure 2.6: Summary of the literature research flow honing-in on Gauteng 
A global view was done with 16 countries including the BRICS nations. The BRICS 
nations provided input that could also be relevant to South Africa. South Africa and 
Gauteng took into account the systems of storage, reporting and the eHealth aims of 
the Department of Health. 
2.4 EXTRACT THE DATA 
Pertinent information on the management of vaccination records was summarised and 
presented as described in Figure 2.7. 
 
Figure 2.7: Step 5 – Extract the data 
Data extracted during this stage were grouped into the following categories: 
• The storage of vaccination records globally – This provides a view of the 16 
countries; 
• Investigation of mobile application systems for vaccination record storage – 
These are systems that parents can use to keep track of their child’s vaccination 
records; 
• Challenges experienced with paper-based vaccination record systems – three 
main challenges were identified; 
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• Procedure for the replacement of lost vaccination cards – The steps that 
parents in Gauteng need to follow if their child’s vaccination card is lost; and 
• Electronic health aims of the Department of Health – The aims of the 
Department of Health were used to further justify this research and to design 
e-Vaccination. 
Figure 2.8 is a graphic representation of the data that was researched and 
summarised. Each section has been linked to the concepts as described in Table 2.2. 
 
Figure 2.8: Illustration of the link between this research and the concepts identified by other authors as 
mentioned in Table 2.2 
2.4.1 THE STORAGE OF VACCINATION RECORDS GLOBALLY 
To eliminate vaccine-preventable diseases, an appropriate vaccination coverage rate 
must be achieved (Tozzi et al., 2016). The appropriate number of doses must also be 
administered according to the German Standing Committee on Vaccinations (STIKO) 
for example, two doses for Measles (Sanftenberg et al., 2016). Global immunisation 
rates are however sub-optimal (Chachou et al., 2015). Vaccination coverage is 
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especially lower in developing countries, which leads to preventable mortality 
(Ndirangu et al., 2009). Digital tools can be used for immunisation registries as well as 
dose tracking (Tozzi et al., 2016). Another possible intervention to ensure that 
immunisations are carried out on time is to use reminders (Chachou et al., 2015). This 
research shows that some countries as well as some privately developed vaccination 
record systems support the use of immunisation registries, dose tracking and 
vaccination reminders. 
The European Union Health Commissioner, Vytenis Andriukaitis, stated that the 
European Commission is in support of an electronic immunisation record system that 
can help the European Union member states to improve their cross-border 
collaboration and help to prevent infectious diseases (Michalopoulos, 2017). This 
follows the outbreak of Measles in Europe during 2016/2017 which resulted in 42 
deaths. There are five European (developed) nations covered in this study to 
determine the status of their digital vaccination records.  
BRIC was an association of four of the World’s major emerging economies which was 
founded in 2006 (About BRICS, 2017). South Africa was invited to join the association 
in 2010 by China. The acronym was thereafter changed from BRIC to BRICS. The 
BRICS nations have similar economies and challenges such as poverty. Considering 
the similarities of the BRICS nations, the use and success of electronic vaccination 
cards in any of these nations might yield similar results in Gauteng. The BRICS nations 
were therefore included in the research. 
To better understand the impact of managing vaccination records using digital 
systems, other countries were considered in this study. For each country the following 
data sets were considered:  
• Population; 
• Vaccination coverage; and 
• System used to manage the vaccination records (digital, physical or hybrid of 
both). 
To include diversity into this study, at least one country from each continent as well as 
two other African countries were considered as part of this research. The results of 
the research per country have been detailed below. 
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Estonia 
Continent:     Europe 
Economic status:    Developed 
BRICS association:    Non-BRICS nation 
Population (2018):    1 323 000 
Vaccination coverage (2018): 91% 
The information above is based on the World Health Organization (2019b). 
Estonia is the first country globally to have implemented a nationwide EHR system 
(Nicholson, 2012). The system contains nearly all of the resident’s medical records 
from birth to death. Since 2008, health data in Estonia is 95% digitised (e-Estonia, 
2016) and (e-Estonia, 2018). The Estonian National Health Information System has 
over 20 000 000 health documents (records) including vaccination records. Toomas 
Hendrik Ilves, the former president of Estonia, stated that the effective use of electronic 
health solutions will allow Estonia to make healthcare services more flexible (e-
Estonia, 2016). The consequence of this will be improved health of Estonians, 
increased awareness of the patients and savings in billions of Euros. The key to 
Estonia’s EHR system is their electronic ID-card system which was built using KSI 
Blockchain technology. This ensures the integrity of the country’s vital health data as 
well as the residents’ personal data. 
Norway 
Continent:     Europe 
Economic status:    Developed 
BRICS association:    Non-BRICS nation 
Population (2018):    5 338 000 
Vaccination coverage (2018):  97% 
The information above is based on the World Health Organization (2019c). 
In 2016, Norway had already implemented EMR systems such as the National Health 
Portal, Norwegian Health Net, Summary Care Record and e-Prescription (Roland, 
2016). Such systems store information such as medicines prescribed, hospitalisation, 
doctor’s visits, emergencies as well as vaccination records. 
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The Netherlands 
Continent:     Europe 
Economic status:    Developed 
BRICS association:    Non-BRICS nation 
Population (2018):    17 060 000 
Vaccination coverage (2018):  93% 
The information above is based on the World Health Organization (2019d). 
Starting in 2008, the Netherlands moved from paper-based records to electronic 
reporting in certain areas of national health care (Alberts et al., 2013). By 2013, all 
vaccinations administered within the National Immunisation Programme (NIP) were 
registered in a centralised electronic database for each citizen (Alberts et al., 2013). 
Based on the information available electronically, the Ministry for Health, Welfare and 
Sport were able to determine that vaccination coverage for the NIP was between 92% 
and 99%.  
Australia 
Continent:     Australia / Oceania 
Economic status:    Developed 
BRICS association:    Non-BRICS nation 
Population (2018):    24 898 000 
Vaccination coverage (2018):  93% 
The information above is based on the World Health Organization (2019e). 
Australia developed the Australian Immunisation Register, which is an electronic 
system that stores children’s immunisation records. Parents can view their child’s 
immunisation records by accessing the Immunisation History Statement on their 
Medicare online account (Department of Human Services, 2018). The Immunisation 
History Statement can be used for school admission requirements.  
The Queensland Government developed a mobile app that parents can use to keep 
track of their children’s immunisation records (Queensland Government, 2018). The 
mobile app called VacciDate is available on the Apple App Store and Google Play. 
The app keeps track of the child’s vaccine schedule and does not interface with the 
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Australian Government. All the data is stored on the mobile devices local database 
based on the Terms and Conditions (Apple Inc., 2018a).  
The VaxOnTime mobile app was developed by the Victorian Department of Health 
and Human Services to remind parents when their child’s vaccinations are due 
(Victoria State Government, 2015). This app is available on the Google Play Store as 
well as the Apple App Store, (Google Play, 2018) and (Apple Inc., 2018c).  
New Zealand 
Continent:     Australia/Oceania 
Economic status:    Developed 
BRICS association:    Non-BRICS nation 
Population (2018):    4 743 000 
Vaccination coverage (2018):  84% 
The information above is based on the World Health Organization (2019f). 
New Zealand has developed a National Immunisation Register (NIR). The NIR is an 
electronic information system that stores the immunisation records of adults and 
children (Ministry of Health, 2015). The aim of the NIR is to increase immunisation 
rates in New Zealand. To ensure that immunisations are given on time, authorised 
healthcare professionals can use the NIR to access a child’s immunisation records. 
Parents and guardians can request their child’s immunisation records from their local 
District Health Board (DHB) (Ministry of Health, 2016) which uses the NIR. Only 
authorised health care professionals can update the NIR. 
Mongolia 
Continent:     Asia 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    3 170 000 
Vaccination coverage (2018):  98% 
The information above is based on the World Health Organization (2019g). 
Electronic registers should accompany quality assurance procedures for the 
monitoring of vaccination programmes (Chan et al., 2017). In Mongolia, an electronic 
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system was used to capture vaccination records. Data were gathered from 06 June 
2016 to 24 August 2016 and showed that a total of 19 879 PCV13 vaccinations were 
recorded. The system has not yet been rolled out across the entire country.  
Vietnam 
Continent:     Asia 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    95 546 000 
Vaccination coverage (2018):  84% 
The information above is based on the World Health Organization (2019h). 
In 2012, Vietnam’s National Expanded Immunization Program collaborated with PATH 
to find ways to improve the immunisation coverage in women and children. They 
developed a pilot system called ImmReg, which is a digital database that housed and 
tracked immunisation records in the Ben Tre province (PATH, 2017). Within five years, 
the success of this pilot system led to its evolution into the Vietnam’s National 
Immunization Information System. Figure 2.9 shows the piles of paper-based records 
created prior to the implementation of the digital system. 
 
Figure 2.9: A photograph of how the immunisation records were captured in the previous paper-based 
immunisation record system in Vietnam (PATH, 2017) 
Mexico 
Continent:     North America 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    126 191 000 
Vaccination coverage (2018):  90% 
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The information above is based on the World Health Organization (2019i). 
Vaccination cards are used in Mexico to store children’s vaccination records (Hospital 
CMQ, 2020). In 2016, the Electronic Immunization Record, CEV, (Cartilla Electrónica 
de Vacunación) was created to capture and store real time vaccination records 
(Fundacion Carlos Slim, 2016). The system stores vaccination records for life, 
including adult vaccines such as the Influenza vaccine. A hybrid system of both 
paper-based and electronic is therefore used in Mexico. 
Uruguay 
Continent:     South America 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    3 449 000 
Vaccination coverage (2018):  94% 
The information above is based on the World Health Organization (2019j). 
Uruguay released a National Immunization Program Register (SNNI) in 1987, which 
was a hybrid paper-based and electronic system (Westley et al., 2014). A physical 
vaccination record form is filled in at the healthcare facility where the vaccine is 
administered. These forms were collected and captured into a national computerised 
database. The SNNI system produced great results due to its high data quality and 
was touted as a great success by the Pan American Health Organization. Since 2005, 
the SNNI has been moving towards a fully electronic model. This would include 
electronic data entry and removing the need for a physical vaccination form.  
Sierra Leone 
Continent:     Africa 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    7 650 000 
Vaccination coverage (2018):  91% 
The information above is based on the World Health Organization (2019k). 
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Vaccine-preventable diseases constitute 30% of the causes of death among children 
under the age of 5 in Sierra Leone (eHealth Africa, 2018). This lead to the launching 
of an Electronic Vaccination Record and Tracking Project called VaxTrac, which was 
an electronic registry of children’s immunisations in 2016 (Kombian, 2017). The pilot 
phase of VaxTrac ran from November 2016 to June 2017. There were 110 health 
officials and 50 workers from 50 health care facilities that were trained on the use of 
VaxTrac. Biometric indicators such as fingerprints are used by caregivers to generate 
patient profiles. Quick Response code stickers on the paper-based vaccination cards 
are also used. Over 20 000 patients have been registered on VaxTrac.  
Tanzania 
Continent:     Africa 
Economic status:    Developing 
BRICS association:    Non-BRICS nation 
Population (2018):    56 313 000  
Vaccination coverage (2018):  95%  
The information above is based on the World Health Organization (2019l). 
In 2015, Tanzania embarked on a project with PATH and BID Initiative to launch an 
immunisation registry (Intrahealth, 2015). The aim of the project was to digitise the 
stock management, service delivery and administration for the vaccination of 
2 000 000 babies per year. The system would keep track of all of the children’s vaccine 
encounters and share the information with Tanzania’s other health information 
systems.  
Brazil 
Continent:     South America 
Economic status:    Developing 
BRICS association:    BRICS nation 
Population (2018):    209 469 000  
Vaccination coverage (2018):  85%  
The information above is based on the World Health Organization (2019m). 
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Brazil has an area of approximately 8 500 000 Square kilometres, making it the fifth 
largest country in the World (Statista - The Statistics Portal, 2018).  
Brazil has a highly effective National Immunization Programme (NIP) with a routing 
vaccination coverage above 95% (WHO, 2017). The recommended coverage by the 
WHO is 90%. Annually, Brazil provides more than 300 000 000 vaccination dosages. 
One of the major challenges that the Brazil NIP faces is access to remote communities 
deep within the Amazon jungle. Nevertheless, these communities are still reached and 
the children therein are vaccinated (WHO, 2017). Figure 2.10 illustrates the transport 
mechanisms used to send vaccines to remote locations in Brazil. Some locations 
cannot be access via road.  
 
Figure 2.10: Depiction of the transport mechanisms used to send vaccines to remote areas in Brazil 
(WHO, 2017) 
At the clinic, a mother will receive a vaccination card the first time a child is vaccinated. 
The nurse writes down the necessary details on the vaccination card which the mother 
will then keep. The Nurse also captures the information from these vaccination cards 
into Brazil’s NIP even in these remote areas. The nurses are also able to determine 
whether the child’s vaccinations are up to date using Brazil’s NIP (WHO, 2017). 
Russia 
Continent:     Asia 
Economic status:    Economy in transition 
BRICS association:    BRICS nation 
Population (2018):    145 734 000  
Vaccination coverage (2018):  95%  
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The information above is based on the World Health Organization (2019n). 
Russia has an area of 17 000 000 Square kilometres making it the largest country in 
the World.  
In 2012, Russia turned to IBM to create digital medical records for healthcare facilities 
outside of their largest cities such as Moscow and St. Petersburg (IBM, 2012). Though 
there has been progress in Russia’s digital healthcare (Health Information 
Translations, 2016), parents are still required to bring their child’s vaccination card to 
the healthcare facility for recording of immunisations. 
India 
Continent:     Asia 
Economic status:    Developing 
BRICS association:    BRICS nation 
Population (2018):    1 352 642 000 
Vaccination coverage (2018):  83% 
The information above is based on the World Health Organization (2019o). 
India has an area of 3 287 240 Square kilometres (Office of the Registrar General & 
Census Commissioner India, 2001). India is the 7th largest country in the World 
(National Portal of India, 2018). 
India aims to immunize approximately 156 000 000 women and children annually 
(Cilliers, 2017). Increasing immunisation compliance will result in a large decrease in 
the death and disability rates in India due to vaccine preventable diseases. As at 2016, 
over 2 000 000 children die each year and a further 1 000 000 children are disabled 
each year due to vaccine preventable diseases.  
Immunize India is the World’s largest vaccination reminder service (Immunize India, 
2016). It is national non-profit initiative supported by the Indian Academy of 
Paediatrics, available to parents in India at no charge. Vaccination reminder services 
in other countries have increased compliance by 20% (Immunize India, 2016). 
Vaccination reminders will be sent to the registered mobile numbers until the child is 
12 years old. There are three reminders, sent two days apart for each for each 
vaccination.  
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Based on the design of the system, each child is not uniquely identified, and a 
complete record cannot be captured. Once a registered child has been vaccinated, 
the child’s vaccination records is not updated. This system is therefore not an end to 
end solution.  
China 
Continent:     Asia 
Economic status:    Developing 
BRICS association:    BRICS nation 
Population (2018):    1 427 648 000  
Vaccination coverage (2018):  99% 
The information above is based on the World Health Organization (2019p). 
China is approximately 9 600 000 Square kilometres (The State Council of the 
People’s Republic of China, 2005). It is the World’s 4th largest country (Worldatlas, 
2018).  
China has not made the digital advances that healthcare consultants had hoped for 
(Shobert, 2017) and m-Health is still in its infancy (Lam, 2017). Some of the reasons 
that the advances were not made are as follows (Shobert, 2017): 
• Chinese families and healthcare professionals had challenges with access and 
affordability of digital systems; 
• Digital m-Health start-up companies monetised their platforms by offering 
advertising on the applications; 
• The benefit to healthcare professionals who needed to use the digital systems 
was not always clear; and 
• Many of the healthcare professionals were not trained in the use of the 
applications and therefore did not use them correctly. 
China Mobile launched pilot m-Health studies in the Guangdong, Guizhou, and Tianjin 
provinces in partnership with the University of Cambridge (Lam, 2017). The following 
programmes were launched: 
• Medical Link; 
• Medicine Link; 
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• Vaccine Link; and 
• Patient Link. 
The aims of these pilot studies were: 
• To deliver medical, health, and wellness information via SMS; 
• Improve access to doctors via SMS communication; 
• Provide vaccine-related information for families; 
• Aid in self-diagnosis; 
• Create a caller operating system for appointment bookings and a better system 
for managing patient information; 
• Allow for mobile video consultations; 
• Provide remote diagnosis and infectious disease tracking; and 
• Enable radio-frequency identification tracking for drugs. 
One of the reasons for the success of these pilots was the strong existing 
telecommunications infrastructure.  
Though the pilots were successful, China is still in the research phase of their digital 
healthcare strategies for general medical care as well as vaccination records. There 
is no fully functioning electronic system for vaccination records. 
South Africa 
Continent:     Africa 
Economic status:    Developing 
BRICS association:    BRICS nation 
Population (2018):    57 793 000 
Vaccination coverage (2018):  79% 
The information above is based on the World Health Organization (2019q). 
South Africa has an area of 1 220 813 Square kilometres (South African Government, 
2018).  
One of the Department of Health’s eHealth strategic aims is to create a National 
Electronic Health Record System (Department of Health, 2012). This includes the 
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creation of an Electronic Health Record, which includes immunisation records 
(Kleynhans, 2011).  
An information dissemination system called MomConnect was developed by the 
Department of Health to provide new and expectant mothers information on child 
healthcare via SMS (Department of Health, 2020). The information sent to the 
mothers, stops when the child turns one year old. The system does not remind 
mothers to have their child vaccinated.  
There is currently no fully electronic end to end system in place.  
2.4.2 SUMMARY OF THE RESEARCHED COUNTRIES 
Table 2.4 is a summary of the countries that were investigated. It highlights each 
country’s BRICS association, economic status, continent, population, number of births 











































































































































Estonia No Developed Europe 1 323 000 91% Yes 
Norway No Developed Europe 5 338 000 97% Yes 
The 
Netherlands 
No Developed Europe 17 060 000 93% Yes 
Australia No Developed 
Australia / 
Oceania 






4 743 000 84% Yes 
Mongolia No Developing Asia 3 170 000 98% No 






126 191 000 90% 
Hybrid of electronic 
and physical 
Uruguay No Developing 
South 
America 
3 449 000 94% No 
Sierra 
Leone 
No Developing Africa 7 650 000 91% No 
Tanzania No Developing Africa 56 313 000 95% Yes 
Brazil Yes Developing 
South 
America 
209 469 000 85% 






Asia 145 734 000 95% 
Hybrid of electronic 
and physical 
India Yes Developing Asia 1 352 642 000 83% No 






57 793 000 79% No 
Figure 2.11 highlights the various countries that were considered in this study. This 
visual depiction shows a representation from a global and continental perspective. It 
also represents the extent of the usage of digital systems for the management of 
vaccination records by highlighting them in either green, amber, red or grey. 
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Figure 2.11: The vaccination record systems of the highlighted countries were investigated. This map 
was created by utilising the map chart tool created by mapchart.net (2019) 
2.4.3 SUMMARY OF THE USE OF DIGITAL HEALTH SYSTEMS IN THE BRICS 
NATIONS 
The investigation of the use of digital health systems in the storage of vaccination 
records in the BRICS nations showed different trends amongst some of the countries. 
It was found that India, China and South Africa do not have a fully functioning end to 
end digital system that manages vaccination records. Brazil and Russia were found to 
have fully functioning end to end digital systems in place however, these countries still 
use the physical vaccination card in addition to these systems.  




Figure 2.12: Summary of the outcomes of the investigation into the use of digital vaccination record 
management systems in the BRICS nations 
Although the BRICS nations are similar in economic growth and social challenges, 
40% of them have a fully functioning end to end electronic vaccination record system. 
The Department of Health’s eHealth aims discussed in later make it clear that South 
Africa aims to move to electronic records which includes vaccination records. The 
trend amongst the BRICS nations is to digitise vaccination records.  
2.4.4 INVESTIGATION OF MOBILE APPLICATION SYSTEMS FOR VACCINATION 
RECORD STORAGE 
Using a mobile app platform can potentially help to overcome certain health challenges 
such as oral diseases (Nolen et al., 2018). Since mobile apps can be used for the 
management of various types of health records, they were included in this study. 
Various non-government based mobile apps were investigated to determine what 
information was stored, where the information is stored and whether there are other 
automatic processes that could be beneficial to e-Vaccination. Table 2.5 summarises 
the results of this investigation.  
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Vaccine Reminder P P P O P P O 
Vaccines Log – Vaccination 
Reminder & Tracker 
P P P P P P P 
Child Immunisation Tracker – 
Baby Immunisation 
P P P O O O O 
My Kids Vaccine Tracking P P P O O P O 
My Immunizations P P P P P O O 
The vaccination record systems summarised in Table 2.5 show that not all the key 
features are built into every system. Based on the Department of Health’s eHealth 
aims, it is important to have a system that centralises vaccination records and thereby 
allow for information to be easily accessed by appropriate authorities. None of the 
systems in Table 2.5 send vaccination information to Government systems. In South 
Africa, there are four possible vaccination schedules (Fedhealth, 2019). It is therefore 
important to ensure that different schedules are catered for as the vaccination dates 
would differ. The investigated mobile applications are discussed below.  
Vaccine Reminder 
Pediatric OnCall (Pediatric Oncall, 2019) is a child healthcare website that offers a 
mobile app developed by Pediatric Oncall Private Limited, to help parents keep track 
of their child’s immunisations. The mobile app called Vaccine Reminder can be 
downloaded off the Apple App Store (Apple Inc., 2018b). This mobile app is private 
and does not interface with government systems. The features of the system are: 
• Parents can register their child on the application; 
• Parents can view their child’s vaccination records; 
• The Vaccination charts and schedules are based on the Centers for Disease 
Control and Prevention (CDC) vaccination schedule; and 
• Parents who have registered for the app will also receive vaccine reminders a 
few days before their child’s vaccines are due. 
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The data stored in the system are listed in Table 2.6 and an overview of the system 
illustrated in Figure 2.13.  
Table 2.6: Data stored in the Vaccine Reminder mobile application 





Parent E-mail address 







Figure 2.13: Screenshots of Vaccine Reminder  
Vaccines Log – Vaccination Reminder & Tracker 
Vaccines Log – Vaccination Reminder & Tracker is a mobile app developed by 
LINKLINKS LTD (LINKLINKS, 2018), available on the Apple App Store (Apple, 
2018d). It is used to record children’s vaccination records and to also check the 
vaccination schedule. The app can be downloaded for free and offers In-App 
purchases. Although the app can be downloaded for free, there is an advertising 
banner on the top of the app. There is no registration required for this app. All records 
created are stored on the mobile devices local database and not in a centralised cloud. 
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If the mobile app is deleted, the data will also be lost. The app has the following 
features: 
• Parents can add an unlimited number of children to the app and check each 
child’s schedule separately; 
• Vaccination records can be logged on the app; 
• Parents can view their child’s vaccination record; 
• Parents can set reminders for their child’s next vaccine; 
• Passcode protection; 
• Vaccine logs can be exported via E-mail; and 
• Parents can check the CDC program for each age group. 
The data stored on the system are listed in Table 2.7 and an overview of the system 
is provided in Figure 2.14. 
Table 2.7: Data stored in the Vaccines Log mobile application 
Data category Field name 
Child Name 
Date of birth 
Gender 
Blood type 










Disease that the vaccine prevents against 
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Figure 2.14: Screenshots of Vaccination Reminder and Tracker  
Child Immunisation Tracker – Baby Immunisation 
Child Immunisation Tracker – Baby Immunisation is a mobile app developed by 
Impressol (Impressol, 2018), also available on the Apple App Store (Apple, 2018a). 
The app can be downloaded and used at no cost. There are, however advertising 
pop-ups on the app. There is no registration required for this app. All records created 
are stored on the mobile devices local database and not in a centralized cloud. If the 
mobile app is deleted, the data will also be lost. The features of the system are listed 
below: 
• Parents can register their child; 
• Parents can add a vaccination record; and 
• Parents can view their child’s vaccination records. 
The data stored on the system are listed in Table 2.8, followed by an overview of the 
system in Figure 2.15. 
Table 2.8: Data stored in the Child Immunisation Tracker mobile application 
Data Category Field name 
Child Name 
















Disease that the vaccine prevents against 
 
Figure 2.15: Screenshots of Child Immunisation Tracker – Baby Immunisation 
My Kids Vaccine Tracking  
My Kids Vaccine Tracking is a mobile app available on the Apple App Store (Apple, 
2018c). The app can be purchased for $0,99 internationally or for R14,99 from the 
South African Apple App Store. The features of the system are listed below: 
• Parents can add an unlimited number of children; 
• Parents can add a vaccination record; 
• Parents can view their child’s vaccination history; and 
• Allows parents to track their child’s vaccinations according to the CDC 
schedule. 
Data stored on the system are listed in Table 2.9 and an overview of the system is 
shown in Figure 2.16. 
Table 2.9: Data stored in the My Kids Vaccine Tracking mobile application 
Data category Field name 
Child Name 
Date of birth 
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Date of vaccine 
Status 
Disease that the vaccine prevents against 
 
Figure 2.16: Sample upcoming vaccinations of My Kids Vaccine Tracking  
My Immunizations 
My immunizations is a mobile app that is available on the Apple App Store (Apple, 
2018b). The features of the system are listed below: 
• Parents can add their children to the app as members; 
• Parents can add vaccination records for their children; 
• Parents can view vaccination records; 
• Parents can send PDF versions of their child’s vaccination records themselves 
so that it can be printed as a physical paper copy; and 
• Vaccination reminders. 
 39 
The data stored on the system are listed in Table 2.10 and in Figure 2.17, an overview 
of the system is provided. 
Table 2.10: Data stored in the My Immunizations mobile application 
Data Category Field Name 
Child Name 






Date of vaccine 
Status 
Disease that the vaccine prevents against 
Figure 2.17: Screenshots of My Immunizations  
2.4.5 SUMMARY OF THE FEATURES BUILT INTO THE INVESTIGATED MOBILE 
APPLICATIONS AND THE INFORMATION STORED 
Table 2.11 contains a summary of the features available across the various mobile 
applications investigated. 
Table 2.11: Summary of the features built into the investigated mobile applications 
Feature Description 
Register child Parents can register their children on the application and 
thereafter track their vaccination records 




Share vaccination records Parents can share their child’s vaccination record via E-mail or 
print out a physical copy 
View vaccination records Parents can view their child’s vaccination records 
Set a vaccination reminder Reminders can be set so that the parent is alerted before their 
child’s vaccination is due 
Track vaccinations according to 
CDC schedule 
Vaccinations can be tracked based on the various CDC 
schedules 
Passcode protection The application can be protected via a passcode 
The features in Table 2.11 were considered during the design and build of 
e-Vaccination. Not all the features were incorporated into e-Vaccination as prototypes 
are normally built with limited purposes (Houde & Hill, 1997). This is discussed in detail 
in Chapter 4. 
Table 2.12 contains all the data stored across the various mobile application systems. 
This information was considered in the development of e-Vaccination. For the 
purposes of making the prototype easier to use, not all the data fields were included 
in the final design.  
Table 2.12: Summary of the data stored in the investigated mobile applications 
Data Category Field Name 
Child Name 

















Data Category Field Name 
Disease that the vaccine prevents against 
2.4.6 CHALLENGES EXPERIENCED WITH PAPER-BASED VACCINATION 
RECORD SYSTEMS 
In addition to the usage of paper-based versus electronic vaccination record systems, 
a review of the literature, journals and other artefacts revealed three main challenges 
experienced by paper-based vaccination record systems. These are; vulnerability, 
accessibility and reliability (Figure 2.18) along with the respective challenges faced 
by paper-based record systems. 
 
Figure 2.18: Summary of the three main challenges with the physical vaccination card in Gauteng 
The challenges were then explored in further detail, as summarised below: 
• Vulnerability: 
o The vaccination record is susceptible to physical damage or loss. 
• Accessibility: 
o Accessing the vaccination record requires that the physical vaccination 
card must be present. If the vaccination card is not present, the 
vaccination records cannot be accessed by any other means. 
• Reliability: 
o The accuracy or correctness of the vaccination statistics cannot be 
totally relied upon due to the amount of manual entry by medical 
practitioners. 
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In 2013, there were 118 government clinics offering immunisations in the City of 
Johannesburg region alone (City of Johannesburg, 2018). When a child is born in 
Gauteng, the parents are given a physical vaccination card called the “Road to Health” 
card (Department of Health, 2019b). It is the responsibility of the parent to keep the 
vaccination card safe and to produce the card every time the child is vaccinated 
(Naidoo et al., 2018). The nurse who immunises the child is responsible for capturing 
the details of the vaccination on the vaccination card. 
The Road to Health card in Figure 2.19, must be brought with the child to every clinic 
visit (Department of Health, 2018). 
Figure 2.19: Road to health vaccination card for girls and boys used in Gauteng (Department of Health, 
2018) 
This card stores the immunisation records of the child as well as clinic visits, clinic 
assessments such as signs of malnutrition, milestones such as dates for crawling, as 
well as tips for parents to keep their child healthy. This booklet stores a lot of 
information regarding the child’s health. Losing this booklet could mean losing this vital 
information.  
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Threats to the physical vaccination card within the context of this study (Gauteng) are 
discussed below. 
Vulnerability of Physical Vaccination Cards 
In Gauteng, fire hazards pose a threat to physical vaccination cards. The Fire 
Protection Association of Southern Africa (Fire Protection Association, 2018) contains 
the reports on all fires that have occurred within South Africa. The latest report as at 
13 July 2017 is for the year 2014. In 2014, there were 185 fires which affected informal 
dwellings in Johannesburg, Gauteng. Fires that result in the destruction of these 
dwellings together with their contents, will also result in the loss of documentation such 
as vaccination cards. Without another copy of the child’s vaccination card, these 
records would be lost. About 2 642 dwellings were affected by fires from 2011 to 2014 
(Table 2.13) (Fire Protection Association, 2018). This poses a threat to health 
documentation such as physical vaccination cards.  
Table 2.13: The number of formal and informal dwellings in Johannesburg, Gauteng affected by fires 
from 2011 to 2014 
Year Number of formal 
dwellings 
Number of informal 
dwellings 
Total per year 
2011 390 345 735 
2012 372 353 725 
2013 412 373 785 
2014 212 185 397 
Gauteng is the economic hub of South Africa (Stats SA, 2018b). The Gauteng province 
attracts people from other provinces due to job prospects (economic migration). It is 
estimated that between 2016 and 2021, 1 048 440 people would have moved from 
other South African provinces to Gauteng (Stats SA, 2018a). This migration will result 
in families with minors being moved. This poses a threat to the paper-based records 
such as vaccination cards being lost during that migration. 
Inaccessibility of Vaccination Records  
The physical vaccination card in Gauteng (the Road to Health card) is the single 
source of vaccination information for each child in Gauteng. As a result, this card has 
to be present to determine whether a child has been vaccinated in accordance with 
the vaccination schedule or not (Figure 2.20).  
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Figure 2.20: Summary of the South African vaccination programmes (Fedhealth, 2019) 
South Africa has four vaccination schedules or programmes that parents can adhere 
to when having their children immunised. These schedules are: EPI (Expanded 
Programme on Immunisation) schedule, Private Practice Option 1, Private Practice 
Option 2 and Private Practice Option 3, (Fedhealth, 2019). 
The minimum vaccination requirement in South Africa as described by Fedhealth on 
the image in Figure 2.21, consists of 19 vaccines which need to be administered to 




Figure 2.21: The South African vaccination schedule (Fedhealth, 2019) 
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Based on these vaccination schedules, the vaccination card must be kept updated 
and safe for a minimum period of 12 years. Even if a physical document such as a 
vaccination card is kept safe, there is a possibility of damage over the 12 year 
vaccination period. In addition, vaccination cards are printed and prepopulated based 
on the vaccines that are available at that point in time. The introduction of new 
vaccines therefore poses a challenge, as vaccination cards that have already been 
printed and distributed to parents cannot be accessed in order for the cards to be 
updated. Parents and guardians will also not be aware of the new vaccines that are 
available. 
The vaccination card is required during the admissions process of children into public 
schools (Brand South Africa, 2015). In the case of private schools, this can differ from 
school to school. A random sample of 24 schools were investigated to determine 
whether vaccination cards were required upon admission. The results show that of the 
24 schools investigated, 41,7% require a copy of the child’s vaccination card upon 
admission or registration. In addition, minors in Gauteng can also be vaccinated in 
their school as part of the school health programme (Department of Health, 2019a).  
A summary of the vaccination requirements in a random sample of 24 Gauteng 
schools is depicted below and further information is documented in Appendix 7. 
 
Figure 2.22: Summary of the vaccination card requirements based on a sample of 24 schools in 
Gauteng 
In each instance, that is, an adm0issions process or vaccinating a child at school, the 
vaccination record of each child will need to be present in order to determine the child’s 
vaccination status and to update the vaccination record. If the card is not present, this 
could result in the child not being accepted at a particular school, in relation to the 
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admissions process; or being re-vaccinated or not vaccinated, in relation to 
vaccinating a child at school. 
The lack of access to up to date information can pose a threat during epidemic 
outbreaks. From all the common childhood viral illnesses, Measles is the most serious 
(Health24, 2018). It forms a red rash on the skin and its symptoms include a high fever, 
cough and a runny nose. See Appendix 8 for an image of the Measles rash. 
In May 2017, an outbreak of the Measles virus was detected in Gauteng with 17 cases 
detected as early as the 08th May 2017 (Mdhluli, 2017). The MEC for Health in 
Gauteng at the time, Dr Gwen Ramokgopa, said that immunisation centres would be 
setup at health facilities with the aim of immunising around 1 million children. The 
Department of Health undertook a mass Measles vaccination campaign (National 
Institute for Communicable Diseases, 2017). The aim was to vaccinate children from 
six months to five years of age. The Measles immunisation rates in South Africa are 
documented in Appendix 9. 
In a situation such as this, where there is an outbreak of a vaccine preventable 
disease, a child’s vaccine records are vital to determine whether the child has been 
vaccinated against this disease or not. It is possible that many children would have 
been revaccinated against the Measles virus which can be traumatic for small children 
(Orenius et al., 2018).  
A study done in Shenzen, China (a BRICS economy) showed that the parental 
recollection of their children’s vaccination status for the Measles virus slightly over 
estimated the actual vaccination status of the children (Liu et al., 2017). In that study, 
163 children who had an electronic record of their vaccination status were considered. 
The study found that 48,5% of parents reported that their children were vaccinated 
against the Measles virus however the electronic records showed that 41,7% of the 
children were vaccinated against the Measles virus. 
A similar study conducted in California, USA, took into account 54 066 participants, 
who were asked whether they had received the Smallpox vaccination (LeardMann et 
al., 2007). Their responses could be checked against their electronic vaccination 
record as there was an electronic system in place. When comparing the participants’ 
recollection of whether they had been vaccinated against Smallpox and their electronic 
record, it was found that 84% of the responses matched. 
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In both these studies, there is a slight difference between information recalled by the 
participants and the electronic record of the child’s vaccination status. It should be 
noted however, that in both instances, there was an electronic record of the 
vaccination with which to compare. In Gauteng there is no electronic record for parents 
to rely on in the event that a vaccination card is lost. In cases where a child’s 
vaccination records are lost and the parents are unable to remember the vaccinations 
that the child has had, the child will have to be re-vaccinated (Child Healthcare, 2018). 
There has not been any vaccination recall incidents in South Africa as yet. On 26 April 
2010 however, the WHO and UNICEF (WHO and UNICEF, 2010) announced a recall 
of the Shan5 vaccine. The Shan5 vaccine was produced in India by Shantha 
Biotechnics. The WHO and UNICEF recommended that all Shan5 vaccines 
manufactured by Shantha Biotechnics be destroyed due to incidents of a white 
sediment sticking to vials. There were no reported side effects of the white sediment 
or the vaccine, the recall was just a precautionary measure. 
Should a vaccine recall occur in Gauteng, the paper-based vaccine record system will 
not be adequate in immediately identifying the children who had received the vaccine 
from a specific batch. An electronic vaccine record storage system could be used to 
determine which children received vaccines from the affected batch of vaccines. Their 
parents could then be contacted so that they can take the necessary steps to 
revaccinate their child. The current paper-based system therefore poses a significant 
threat to children who have received a recalled vaccine as there is no easy way to 
access or identify these children. 
Unreliability and Limited Usability of Vaccination Data 
The information flow for paper-based vaccination records is one way. Once the 
medical professional administers the vaccine, the details are captured on the 
vaccination card. There is not always a mechanism that takes the details of the child 
or the record of the vaccination and sends it back to a central repository. As a result 
of this one-way information flow, the validity of vaccination data can be challenged by 
external or internal organisations.  
The accuracy of vaccination statistics can be affected if the information that feeds into 
the reports is not up to date or accurate. Figure 2.23 illustrates the flow of vaccination 
data from a health facility or clinic in South African to the WHO (van den Heever, 
 49 
2012). The child’s details are verified against the child register at the healthcare facility. 
From there, the data is tallied and compiled into a Health Facility report for each health 
facility. Data from the various health facilities within each district is then combined into 
District Tabulations. All the District Tabulations within each province are then grouped 
and combined into the Province Reports which then form part of the National 
Tabulations. This is compiled into a Joint report that is sent to the WHO. 
Figure 2.23: Depiction of the vaccination data flow from health facility to national level. The data flow 
cycle occurs every 45 days (van den Heever, 2012) 
Based on the flow in Figure 2.23, it appears that the vaccination statistics at a national 
level and at the WHO would be the same, but this is not the case. The Department of 
Health reported a 96% vaccination rate in South Africa whereas the WHO reported a 
rate of 64% (Dyosop, 2012). The vaccination statistics of South Africa reported by both 
the Department of Health and the WHO are flawed (Dyosop, 2012).  
The Head of the Department of Health’s Expanded Programme on Immunisation 
(EPI), Johann van den Heever also disputed the WHO/UNICEF vaccination coverage 
figures (van den Heever, 2012). He does however acknowledge that there are data 
discrepancies in the Department of Health data due to old data collection tools. 
In a study conducted in Canada, it was found that the electronic vaccination record 
system allowed data to be collected, analysed and applied in a rapid fashion 
(Heidebrecht et al., 2014). Positive sentiments about the system were expressed by 
appointment clerks, nurses, registration, implementation and management staff. The 
system was used to record influenza vaccine uptake in addition to the standard 
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required vaccinations. The data were not just stored but also analysed to determine 
trends in immunisation. 
The significant discrepancy in the estimated vaccination rates between the WHO and 
the Department of Health in South Africa demonstrates the high level of unreliability in 
the vaccination statistics of paper-based systems. In addition, when compared to an 
electronic vaccination record system, the usability of the vaccination data, that is, the 
ability to analyse and forecast using the data, is limited. 
The data flow of vaccination records as detailed above is subject to human error at 
almost all points in the collection process. This poses a threat to the accuracy of 
vaccination related data. The manual interventions that arise from the paper-based 
system can result in unreliable and inaccurate data. 
A country that has seen meaningful impact of moving from a paper-based system to 
an electronic records system is Vietnam. The previous paper-based system used in 
Vietnam was cumbersome (PATH, 2017). Generating reports from a paper-based 
system can lead to errors and can be time consuming. By moving from a paper-based 
system to an electronic system, the ImmReg system was able to reduce the amount 
of human errors in manual lists and increase the effectiveness of on-time delivery of 
certain vaccines by up to 20% (PATH, 2017).  
Without the implementation of an electronic vaccination record system, Gauteng is 
unlikely to experience material increase in the accuracy of vaccination data.  
2.4.7 PROCEDURE FOR THE REPLACEMENT OF LOST VACCINATION CARDS  
Since there is no fully automated end to end vaccination record system in Gauteng 
(van den Heever, 2012), losing a vaccination card usually means losing a child’s 
vaccination records. Parental recall can be used to recover the child’s vaccination 
history. In the Measles vaccine study pointed out earlier (Liu et al., 2017), parental 
recall does slightly overestimate vaccination rates.  
In the event of a physical vaccination card being lost or damaged in Gauteng, the 
following process must be followed (Child Healthcare, 2018):  
• The mother should collect a new “Road-to-Health” immunisation card from a 
clinic. This card must be marked as a duplicate; 
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• The nurse should ask the mother which immunisations the child has had 
already;  
• Based on the mother’s recollection of the child’s immunisations, the 
immunisation card will be updated accordingly; and 
• If the mother is uncertain about certain vaccines, these vaccines will be 
administered to the child. 
Provided that the child is not too old, repeating immunisations is not dangerous (Child 
Healthcare, 2018). Re-vaccinating a child can however have adverse psychological 
effects. Needle phobia is a condition that is more common in children and adolescents 
(within vaccination age) than in adults (Orenius et al., 2018). A condition called 
Resistive Needle phobia which is characterised by combativeness, can result in the 
dread of needles and a fear of being controlled (Orenius et al., 2018). Subjecting 
children to re-vaccination could therefore result in an increased fear of injections. 
2.4.8 ELECTRONIC HEALTH AIMS OF THE DEPARTMENT OF HEALTH 
The measure of success of a country’s eHealth maturity is made up of five stages 
(Department of Health, 2012). These stages are summarised in Table 2.14. 
Table 2.14: Summary of the five stages of eHealth maturity in developing countries 
Stage Description 
Stage 1 District health indicators are collected by means of paper-based systems 
Stage 2 The optimisation of the paper-based systems. This is achieved by the simplification of 
information and reducing the amount of duplication 
Stage 3 Converting the paper-based district health information systems into electronic storage 
and reporting 
Stage 4 Introducing working ICT systems as the source of data in the Health Information System 
Stage 5 Integrated and fully comprehensive National Health Information System 
Overall, South Africa is at Stage 3 of eHealth maturity (Department of Health, 2012). 
Some provinces however, are at Stage 4 in certain areas and other provinces at Stage 
1, 2 and 3. The Department of Health has outlined the following steps for South Africa 
to reach Stage 4 and 5 of eHealth maturity: 
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Figure 2.24: The six steps identified by the Department of Health to take South Africa into Stage 4 and 
5 in terms of eHealth (Department of Telecommunications and Postal Services, 2017) 
A summary of the Department of Health’s aims for eHealth are listed in Figure 2.25. 
This is based on a report by the Department of Telecommunications and Postal 
Services (Department of Telecommunications and Postal Services, 2017). 
 
Figure 2.25: Summary of the Department of Health’s aims regarding e-Health, (Department of Health, 
2012) 
The first aim of the Department of Health’s eHealth strategy relates to the accessibility 
challenge currently experienced with the physical vaccination card in Gauteng. The 
rest of the eHealth strategy aims in Figure 2.25 are indirectly related to vaccination 
records.  
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South Africa still relies on the physical vaccination card to record children’s 
immunisation details (Department of Health, 2019b). There is no fully electronic 
system that keeps track of individual children’s vaccination records.  
Though not mentioned in the eHealth aims above, the use of digital records could also 
contribute towards the reporting of herd immunity based on the physical location of 
the minors who have been vaccinated against certain diseases. Early warning 
systems could utilise digital vaccination records for further processing.  
The objective of this research is therefore qualified as it is an extension of the existing 
research regarding electronic health records and supports the aims of the Department 
of Health’s eHealth strategy. 
2.5 SUMMARY OF LITERATURE REVIEW 




Figure 2.26: Summary of Chapter 2 
The five main components of the Literature Review as illustrated in Figure 2.26 were 
Peer Reviewed Papers, Global Assessment, Department of Health Aims and Strategy, 
Current Mechanism and School Admission Requirements. These were investigated to 
determine the feasibility of using an electronic mechanism for the effective 
management of vaccination records in Gauteng. The outcome of this investigation is 
summarised as follows: 
• Peer Reviewed Papers – Evidence shows that countries are moving towards 
digital systems for the management of medical health records. There is lack of 
research done in the area of medical records specifically aimed at vaccination 
records. These papers were listed in Table 2.2. 
• Global Assessment – The assessment of the 16 countries shows that some 
countries are digitising their vaccination record systems. This trend is seen in 
countries regardless of their economic status, continental location or whether 
they are BRICS members or not. This was discussed in Section 2.4.1. 
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• Department of Health – The aims and strategies of the Department of Health 
support the digitising of medical records and to create an electronic health 
record for citizens. Since vaccination records form part of a child’s medical 
history, it should also be included in the overall strategy. This was discussed in 
Section 2.4.8. 
• Current Mechanism – The current paper-based record was used to determine 
the use cases or processes as well as to identify the key stakeholders involved 
with vaccination records. This information was used in the construction of the 
research question as well as the questionnaire that will be discussed in Chapter 
3. 
• School Admission Requirements – A random sample of schools in Gauteng 
revealed that vaccination cards are required upon admission by 41,7% of those 
schools. The school admission requirements were discussed in Section 2.4.6. 
The Literature Review has demonstrated that an investigation on the current 
paper-based vaccination record system in Gauteng is warranted and that replacing it 
with a digital system is potentially feasible.  
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CHAPTER 3: RESEARCH METHODOLOGY 
 
Figure 3.1: Structure of Chapter 3 
3.1 INTRODUCTION 
Elements of a literature review were shared in Chapter 2. This showed that countries 
are moving towards an electronic health record for citizens. Based on the evidence 
presented in Chapter 2, it was found that the vaccination record system used in 
Gauteng, South Africa is largely paper-based. South Africa also aims to digitise 
medical records of its citizens and have identified the steps needed to do so. 
To answer the research question, “What are the perceptions of the key stakeholders 
towards replacing the paper-based vaccination card with an electronic vaccination 
record system?” it was necessary to perform a quantitative research analysis by 
collecting relevant data and analysing it. This chapter shows where and how the data 
were collected. It also describes how the data were prepared and analysed. 
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3.2 RESEARCH AND DESIGN METHOD 
A literature review was conducted to determine the relevance and feasibility of this 
study. It was found that there is not a fully automated system for vaccination records 
management for minors in Gauteng. Countries are increasingly moving towards digital 
systems for the management of medical information (Kleynhans, 2011). This led to 
the design of a prototype electronic vaccination record system (e-Vaccination). This is 
an appropriate method relating to a study involving eHealth (Botha, 2015). A prototype 
system is a way to explore designs for computer systems containing limited purposes 
(Houde & Hill, 1997). e-Vaccination therefore has limited features but can be used to 
demonstrate how an electronic vaccination records management system could 
function. 
To assess the effectiveness of the prototype and to answer the research question, a 
questionnaire was designed to collect feedback from the relevant stakeholders. The 
prototype developed for this study was initially piloted by ten users who provided their 
feedback regarding the system. The prototype was thereafter refined and prepared for 




Figure 3.2: The Research Design Flow 
Figure 3.2 is an illustration of the Research Design Flow. The steps are explained in 
detail below: 
• Literature review – The steps taken in this phase of the research are illustrated 
in Figure 2.2. 
• Prototype – The design and development of a prototype electronic system for 
the management of vaccination records followed an iterative process. The aim 
of the prototype was to demonstrate the usefulness and effectiveness of an 
electronic system with limited features as an end-to-end system is not required 
for a software prototype (Houde & Hill, 1997). It must be noted that although 
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this research involves elements of health informatics, the quasi intervention 
method was not utilised.  
• Pilot (Prototype) – Once the prototype was developed, it was piloted with ten 
test users to ensure that there were no bugs in the system. As this was an 
iterative process, bugs that were identified were fixed and the process 
continued until the prototype was ready for use. 
• Questionnaire – The questionnaire was designed to gather responses on the 
use of an electronic vaccination record system for minors in Gauteng. 
• Pilot (Questionnaire) – The questionnaire was piloted on ten test users to 
ensure that the questions were understandable and worded in a manner that 
avoided ambiguity. Any issues identified with the questionnaire were corrected. 
• Send link to prototype and questionnaire to stakeholders – Once the 
prototype and questionnaire were finalised, stakeholders from the four groups 
were contacted via E-mail, telephone call, instant messaging or by visit.  
• Collect Data – Once the stakeholders completed the questionnaire, the 
responses were submitted electronically in the case of the online submission. 
Although physical questionnaire responses were catered for, all submissions 
were eventually done electronically. 
• Determine Reliability – The Cronbach Alpha was used to determine the 
reliability of the responses. 
• Data Analysis – The data were analysed using a Chi-Square, Analysis of 
Variance and a Principle Component Analysis. 
• Findings – The results of the data analysis were then prepared for the 
conclusion. 
3.3 STUDY POPULATION 
A study conducted by Wang et al., (2015) involving three stakeholder types 
(physicians, medical record staff and patients) revealed that physicians (doctors) had 
the least amount of support in an information system that is used to share information 
between hospitals. We used an adapted approach in this research where four key 
stakeholder types were chosen based on their involvement with vaccination records. 
This is described in Figure 3.3. 
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Figure 3.3: The four key stakeholder groups considered in this research 
• Doctors (Non-specialists or specialists) – Doctors sometimes administer 
vaccinations and have detailed knowledge of vaccinations as well as the 
consequences of losing a vaccination card.  
• Nurses – Nurses administer vaccinations to children. They also work with the 
existing paper-based vaccination card on a daily basis and could provide the 
relevant insight into the use of a digital vaccination management system. 
• Parents (Those who have children under the age of 12) – Parents are 
currently responsible for the storage of their children’s paper-based vaccination 
records. They could also be future users of an electronic vaccination record 
storage system. 
• School administration staff – School administration staff understand the 
entrance requirements of schools. They have insight into the procedures when 
dealing with children who either do not have a valid vaccination record or have 
an incomplete vaccination record. 
The participants of this research were selected using a sample of convenience where 
subjective methods can be used to determine whether a participant should be included 
in the research or not (Battaglia, 2008). 
3.4 THE PILOT 
e-Vaccination was piloted on ten users to ensure that there were no defects. Feedback 
was also considered to refine e-Vaccination, contributing towards a better user 
experience. Table 3.1 is a summary of the feedback received and actions taken.  
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Table 3.1: The feedback received from the pilot phase and the corresponding actions that were taken 
Feedback Action taken 
Reduce the amount of 
typing required for the 
prototype 
Sample parent profiles were created and populated in dropdown 
boxes. This allowed the stakeholders to easily select a child profile 
with which to experiment.  
Do not display features that 
are not available in the 
menu 
Features that are not available in the prototype were coloured in 
grey. 
During the pilot phase, no defects were reported.  
3.5 THE RESEARCH INSTRUMENT 
To answer the research question, it was necessary to collect and analyse data relating 
to e-Vaccination. A questionnaire with three sections was designed to collect 
Demographic Information; Perceptions towards vaccinations in Gauteng; Usefulness, 
Satisfaction and Ease of Use (based on the USE tool) (Lund, 2001) related information 
on e-Vaccination. The USE Tool is a method that is used to measure the usefulness, 
ease of use, ease of learning and satisfaction of a software tool from a users’ 
perspective (Lund, 2001). The three sections are explained in further detail below: 
1. Section A: Respondent Information (Demographics) 
a. This was to determine where the respondent lives and works. Since the 
research is relevant for Gauteng, the respondents needed to either live or 
work in Gauteng; 
b. To determine which of the four key stakeholder groups the respondent 
belonged to; and  
c. To determine whether the stakeholders had access to the Internet, a 
smartphone and an e-mail address. These resources are needed to access 
an electronic system of this nature. 
2. Section B: Vaccinations Records in Gauteng, South Africa 
a. This section was used to determine the stakeholders’ perceptions towards 
the paper-based vaccination card; 
b. To determine whether the stakeholder believed that vaccination records 
should be managed by the Parents/Guardians or Government; and 
c. To determine the stakeholders’ perceptions towards the vaccination rate in 
Gauteng.  
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3. Section C: A Centralised Electronic Vaccination Record System in Gauteng, 
South Africa Managed by the Government 
a. This section of the questionnaire was based on a 5-point Likert scale with the 
five possible responses as {Strongly agree = 5, Agree = 4, Neither agree nor 
disagree = 3, Disagree = 2, Strongly disagree = 1} (Andres & Borabo, 2015; 
Nolen et al., 2018;). These questions, based on the USE tool (Lund, 2001) 
were divided into five sub-categories, that is, Usefulness, Ease of Use, Ease 
of Learning, Satisfaction and, Design and Visual Aids. These sub-categories 
are explained in Table 3.2. 
Table 3.2: Description of the categories in Section C of the questionnaire 
Category Description 
Usefulness The system is useful (Lund, 2001) 
Ease of Use The system is easy to use (Lund, 2001) 
Ease of Learning The system is easy to learn to use (Lund, 2001) 
Satisfaction The user is satisfied with the system and would recommend it to a 
friend (Lund, 2001) 
Design and Visual Aids The design and visual aids such as icons are helpful 
The complete research instrument is found in Appendix 10. The five categories in 
Table 3.2 resulted in the hypotheses listed in Table 3.3. 









Usefulness H0- usefulness e-Vaccination is useful H1- usefulness e-Vaccination is not 
useful 
Ease of Use H0- easy to use e-Vaccination is easy to 
use 
H1- easy to use e-Vaccination is not 
easy to use 
Ease of 
Learning 
H0- easy to learn e-Vaccination is easy to 
learn 
H1- easy to learn e-Vaccination is not 
easy to learn 
Satisfaction H0- satisfaction The stakeholders are 
satisfied with 
e-Vaccination 
H1- satisfaction The stakeholders are 




H0- design and 
visual aids 
The design and visual 
aids of e-Vaccination 
are helpful 
H1- design and 
visual aids 
The design and visual 
aids of e-Vaccination 
are not helpful 
 
3.6 PROCEDURE FOR DATA COLLECTION 
The questionnaire was distributed to the key stakeholders electronically (via the 
prototype). The participants were asked to use e-Vaccination first and then respond to 
the questionnaire. A paper-based version of the questionnaire was also prepared (but 
never used). The responses were anonymous as per a similar study by Wang et al., 
(2015). No identifying details such as names, E-mail addresses or contact numbers 
was collected from the respondents. Respondents to the questionnaire were selected 
using a sample of convenience with their contact details obtained via the Internet in 
some cases. In other cases, word of mouth was used to distribute the link to the 
prototype and questionnaire. Permission to collect data was obtained from the 
institutions as listed in Table 3.4. 
Table 3.4: Details of the research permission obtained for the data collection from the various institutes 
Institute Committee Reference number 
Gauteng Province Health Department Tshwane Research Committee GP_201812_018 
Gauteng Province Health Department Ekurhuleni Health District GP_201812_018 
Ethics approval letters can be found in Appendix 4, 5 and 6.  
3.7 DATA PREPARATION 
Once the questionnaires were filled in and the data collected, the following steps were 
taken to prepare the data for analysis: 
• Responses were filtered to ensure that only those stakeholders living/working 
in Gauteng were considered; 
• Incomplete answers (not applicable) were replaced with the respective 
respondents’ mean (Downey & King, 1998); and 
• Responses to negatively worded Likert-type questions were reversed (Jozsa & 
Morgan, 2017). 
Once these steps were taken, the data were considered ready for analysis. 
 
Figure 3.4: The steps taken to prepare the data collected for analysis 
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3.8 DATA ANALYSIS METHODS AND INTERPRETATION 
Once the dataset was ready for analysis and interpretation, the steps outlined in 
Figure 3.5 were followed.  
 
Figure 3.5: The data analysis steps that were followed 
The data had to be proven reliable before the analysis took place. A Cronbach Alpha 
was used to determine this. In order to confirm that the data collected was not a 
randomised occurrence, a Chi-Square goodness of fit test was followed as a 
subsequent step. Since there were four different stakeholder groups, a comparison of 
the data collected between these groups was done using an Analysis of Variance 
(ANOVA) test. Once it was proven that the data were reliable, not random and that 
stakeholder groups did not have a significant difference between them in their 
responses, a Principle Component Analysis (PCA) was done. The PCA was used to 
determine whether the responses to the questionnaire were related to the overall 
research question. These data analysis steps are discussed in detail below.  
3.8.1 DATA RELIABILITY 
The Cronbach Alpha is used to determine the reliability of a set of questions (Goforth, 
2015). When using a Likert scale, it is imperative to use Cronbach’s alpha to report 
the internal consistency reliability (Gliem & Gliem, 2003). Cronbach Alpha scores are 
expressed as a decimal value from 0 to 1 (Goforth, 2015). The scores are interpreted 
as per Table 3.5. 
Table 3.5: The Cronbach alpha scores and ratings based on the scores (Gliem & Gliem, 2003) 
Score Rating 
>0,9 Excellent 
>0,8 alpha <=0,9 Good 
>0,7 alpha <=0,8 Acceptable 
>0,6 alpha <=0,7 Questionable 
>0,5 alpha <=0,6 Poor 
alpha <0,5 Unacceptable 
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Once the data were collected, the Cronbach Alpha score was calculated for each 
category of Section C of the questionnaire. The score for each category was used to 
determine whether the data were reliable based on scores in Table 3.5. 
3.8.2 ANALYSIS OF THE DATA 
Chi-Square test 
The Chi-Square test is used to determine the likelihood that, an observed distribution 
of categorical data, is due to chance (University of Pennsylvania School of Arts and 
Sciences, 2008). A similar study by McConachie et al., (2020) involving electronic 
health records, used the Chi-Square test to analyse the data. For purposes of this 
research, the Chi-Square test was used to determine if the results obtained were 
based on a random occurrence or whether the results were influenced by another 
variable, which formed the basis of the hypothesis for this test.  
The null hypotheses and associated alternate hypotheses for the Chi-Square test per 
sub-category are listed in Table 3.6.
 
Table 3.6: The null and alternate hypotheses for the Chi-Square test 
Category Null Hypothesis Null Hypothesis Description Alternate 
Hypothesis 
Alternate Hypothesis Description 
Usefulness H0- usefulness Chi-
Square 
The proportions of scores for the usefulness 
category are the same between the observed 
and the expected responses 
H1- usefulness Chi-
Square 
At least 2 proportions of scores for the usefulness 
category are different between the observed and 
the expected responses 
Ease of Use H0- easy to use Chi-
Square 
The proportions of scores for the ease of use 
category are the same between the observed 
and the expected responses 
H1- easy to use Chi-
Square 
At least 2 proportions of scores for the ease of use 
category are different between the observed and 
the expected responses 
Ease of 
Learning 
H0- easy to learn Chi-
Square 
The proportions of scores for the ease of 
learning category are the same between the 
observed and the expected responses 
H1- easy to learn Chi-
Square 
At least 2 proportions of scores for the ease of 
learning category are different between the 
observed and the expected responses 
Satisfaction H0- satisfaction Chi-
Square 
The proportions of scores for the satisfaction 
category are the same between the observed 
and the expected responses 
H1- satisfaction Chi-
Square 
At least 2 proportions of scores for the satisfaction 
category are different between the observed and 
the expected responses 
Design and 
Visual Aids 
H0- design and visual 
aids Chi-Square 
The proportions of scores for the design and 
visual aids category are the same between the 
observed and the expected responses 
H1- design and visual 
aids Chi-Square 
At least 2 proportions of scores for the design and 
visual aids category are different between the 
observed and the expected responses 
 
A 5% significance level and four degrees of freedom were used in the calculation of 
the Chi-Square test. The null hypothesis was rejected if the Chi-Square value was 
greater than the critical value. The critical value is based on the table of Chi-Square 
Statistics (The University of Texas at Austin, 2004). Similarly, if the p value was less 
than the significance level, this means that the probability that random chance is 
causing the observed values to be different from the expected value is extremely 
small, there is therefore a statistical relationship between the variables 
(StatisticsSolutions, 2020). 
Analysis of Variance Test 
The Analysis of Variance (ANOVA) test was used because data was collected from 
more than two stakeholder types. The ANOVA test is used to determine if there are 
significant differences between different experimental conditions (Rutherford, 2000). 
This statistical method was used to analyse Likert-type scales in a similar study by 
Holtz & Krein (2011). In this research, the differences between the means of the 
different stakeholder groups were analysed to determine if the null hypothesis for each 
sub-category was accepted.  
The null hypotheses and associated alternate hypotheses for the ANOVA test per sub-
category are listed in Table 3.7. 










Usefulness H0- usefulness 
ANOVA 
The mean scores for the 
usefulness category across 
the 4 stakeholder groups 
are the same 
H1- usefulness 
ANOVA 
At least 2 mean 
scores for the 
usefulness category 





H0- easy to use 
ANOVA 
The mean scores for the 
ease of use category 
across the 4 stakeholder 
groups are the same 
H1- easy to use 
ANOVA 
At least 2 mean 
scores for the ease of 
use category across 
the 4 stakeholder 
groups are different 
Ease of 
Learning 
H0- easy to learn 
ANOVA 
The mean scores for the 
ease of learning category 
across the 4 stakeholder 
groups are the same 
H1- easy to learn 
ANOVA 
At least 2 mean 
scores for the ease of 
learning category 













Satisfaction H0- satisfaction 
ANOVA 
The mean scores for the 
satisfaction category across 
the 4 stakeholder groups 
are the same 
H1- satisfaction 
ANOVA 
At least 2 mean 
scores for the 
satisfaction category 





H0- design and 
visual aids 
ANOVA 
The mean scores for the 
design and visual aids 
category across the 4 
stakeholder groups are the 
same 
H1- design and 
visual aids ANOVA 
At least 2 mean 
scores for the design 
and visual aids 
category across the 4 
stakeholder groups 
are different 
The degrees of freedom between groups was determined as 3 and as 114 for degrees 
of freedom within groups. These results, together with a 5% level of significance were 
used to calculate the ANOVA test. If the p value was greater than the level of 
significance, it meant that the differences in the responses across the stakeholder 
types was not statistically significant (Minitab Express, 2019), the null hypothesis 
would then be accepted. 
Principle Component Analysis 
A Principle Component Analysis (PCA) is a data reduction method (UCLA Institute for 
Digital Research & Education, 2020) that can be used to investigate a relationship 
between dependent variables (Syms, 2019). In this case, the relationship between the 
responses and the overall concept of digitising the vaccination card as well as the five 
sub-categories relating to Section C of the questionnaire. The dataset used in the PCA 
were the responses of the 118 participants to the 33 questions contained in Section C 
of the questionnaire. A PCA was also conducted in a similar study by Ndirangu et al., 
(2009). 
Prior to conducting the PCA, the Kaiser-Meyer-Olkin (KMO) value was calculated in 
order to determine whether the data was suitable for a PCA, since the KMO value is 
a measure of sampling adequacy (UCLA Institute for Digital Research & Education, 
2020). The KMO value should be greater than 0,5 (David & Jacobs, 2014). 
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Once it had been determined that the dataset was suitable for a PCA, the PCA was 
conducted and the Eigenvalues were calculated to determine the principle 
components of the dataset. Eigenvalues greater than 1 should be kept (UCLA Institute 
for Digital Research & Education, 2020). The Eigenvalues were then used to generate 
a scree plot that was used to determine which of the components identified from the 
PCA were significant.  
3.9 SUMMARY OF RESEARCH METHODOLOGY 
A quantitative analysis of the data was performed to determine the perceptions of the 
key stakeholders. Figure 3.6 is a summary of the data preparation and analysis steps 
that were followed in this study.  
 
Figure 3.6: The steps taken to analyse the responses and formulate the results 
 70 
CHAPTER 4: ARTEFACT 
 
Figure 4.1: Structure of Chapter 4 
4.1 INTRODUCTION 
The prototype (e-Vaccination) was created to demonstrate an electronic version of a 
vaccination record system. Its functionality and design were centred on the four key 
stakeholders (Parents, Doctors, Nurses and School Administrators). The phase in the 
research where e-Vaccination was used is detailed in Figure 3.2. 
4.2 RELEVANCE OF THE DESIGN OF E-VACCINATION TO THE DEPARTMENT 
OF HEALTH’S E-HEALTH AIMS 
The five stages of eHealth maturity in developing countries (Department of Health, 
2012) were introduced in Section 2.4.8 together with the steps identified by the South 
African Department of Health to move South Africa from Stage 3 to Stage 4 and 5 
(Department of Health, 2012). The design of e-Vaccination took into account the 
eHealth maturity stages and the steps needed to move South Africa to Stages 4 & 5 
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(Figure 4.2). e-Vaccination therefore supports 5 out of the 6 steps (Figure 4.2), the 
respective features that support these steps are elaborated in Table 4.1.  
 
Figure 4.2: Summary of the eHealth maturity stages for developing countries together with the steps 
that the Department of Health has identified to move South Africa to stages 4 and 5 
Table 4.1: Summary of the e-Vaccination features that support the steps identified in Figure 4.2 
Step Number Description of e-Vaccination Feature 
1 e-Vaccination is a cloud-based system that can be accessed and used at the 
healthcare facility where the vaccination is being administered, provided there is 
an Internet connection. 
2 With the use of systems integration e-Vaccination can be linked to a national 
health record system. 
3 The electronic vaccination record can be created at the healthcare facility. 
4 e-Vaccination ensures that every minor has a unique identifier.  
6 Since e-Vaccination is a cloud-based system, the information can be accessed 
from anywhere provided there is an Internet connection. 
4.3 DESIGN 
The features built into the investigated mobile applications are detailed in Table 4.2 
as well as whether or not such feature was incorporated into the design of e-
Vaccination or not.  
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Table 4.2: Influence of the researched systems on e-Vaccination, with the rationale for each feature 
Feature Included in 
e-Vaccination 
Rationale 
Register child No Sample parent and child profiles were created for the 
stakeholders to use. This would ensure that the 
stakeholders could get straight into the key features of 
the system. 
Add a vaccination 
record 
Yes Adding a vaccination record is currently an important 
part of vaccination records management. 
Share vaccination 
record 
No The downloading and sharing of vaccination records 
was not included in e-Vaccination to keep the prototype 
lean. 
View a vaccination 
record 
Yes The 4 stakeholder types are able to view vaccination 
records based on the sample profiles. 
Set a vaccination 
reminder 
No To keep e-Vaccination lean, this feature was not built. 
Track vaccinations 
according to CDC 
schedule 
Yes The vaccinations in e-Vaccination were based on the 
South African EPI schedule. 
Passcode protection Yes e-Vaccination requires a passcode to log in. 
As seen in Table 4.2, four out of the seven researched features were included into the 
design and build of e-Vaccination. 
4.3.1 TECHNICAL DESIGN 
In a study conducted by Wang et al., (2015) involving three stakeholder types 
(physicians, medical record staff and patients), it was concluded that policy makers 
should consider incorporating a Cloud-based Healthcare Information System. A 
cloud-based system that houses the application and data in a centralised location was 
therefore created. That system has been hosted by Uniwebserve since 2017 and will 
terminate at the end of 2020. 
e-Vaccination was created using the PHP programming language as a server-side 
scripting language that allows for dynamic content to be displayed on a web page. The 
data is stored on a MySQL database. HTML5 was used to display the information. 
Both these systems are open source, so no development license costs were incurred 
during the development of the prototype.  
The front-end (user interface) is mobile responsive and has been adapted to mobile 
devices. The system therefore renders the best application or usability on a mobile 
device instead of desktop computers. 
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4.3.2 OVERALL ARCHITECTURE 
Figure 4.3 illustrates the overall architecture of e-Vaccination.  
 
Figure 4.3: An illustration of the architecture of e-Vaccination 
As seen in Figure 4.3, the stakeholders can use their Internet enabled devices to 
access e-Vaccination. A request is sent from their device which goes via their ISP 
(Internet Service Provider) by going to www.e-vaccination.co.za in their web browser. 
The e-Vaccination home page will then be displayed.  
Once they enter an access code which was provided along with the link to the system, 
it will be verified, and the stakeholder will be logged in. All the patient and other 
statistics data reside on the MySQL database which is accessed using PHP and 
displayed using HTML5. If the stakeholder’s Internet connection is interrupted, the 
pages will no longer display, and the stakeholder will have to log in once the Internet 
connection is up. 
4.3.3 DATABASE DESIGN 
The database design was based on the data that needed to be stored. The data were 
grouped into tables based on some of the designs of the investigated mobile 
applications as previously summarised in Table 2.12. 
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An Entity Relationship Diagram (ERD), shows a relationship between database 
entities, in this case the tables. It also depicts the relationship types (one to one, one 
to many, many to one, many to many) (w3schools, 2019). Figure 4.4 is an ERD which 
represents the database tables that make up e-Vaccination and how they relate to 
each other. Not all the tables are linked to others, some exist independently.  
 
Figure 4.4: The Entity Relationship Diagram of the e-Vaccination database tables 
The Child table stores the demographic information about the child such as name and 
surname. This table is linked to the Parent table via the Parent_ID field. The Parent 
table stores the parents’ demographic information such as name and surname. The 
link to the Child table via the Parent_ID field works both ways.  
When a vaccination record is created by a stakeholder, a record is added to the 
Child_vaccinations table. This record is linked to the Child record. The Vaccinations 
table contains a list of all the vaccinations. When the stakeholder views the 
vaccinations in a dropdown list, they are being accessed from this table. 
Statistical reports that are available on e-Vaccination are stored in the following tables: 
• Provincial_measles – Measles vaccination rates by province; 
• District_measles – Measles vaccination rates by district; 
• Immunisations_covered_by_district – Overall vaccination rates by district; 
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• Immunisations_covered_by_province – Overall vaccination rates by province; 
• National_immunisation_coverage – Overall vaccination rates at the national 
level; and 
• National_measles – Overall Measles vaccination rates at the national level. 
Once the stakeholder completes the online questionnaire and submits the information, 
this is stored in the Questionnaire_2019 table. 
4.4 PROCESS FLOWS 
The following section details the process flows for each of the stakeholder types. Since 
the stakeholders’ approach vaccination records from different perspectives such as 
adding a vaccination record versus viewing only, different process flows were created. 
4.4.1 PROCESS FLOW: PARENTS 
Figure 4.5 outlines the overall process flow for the “Parent” stakeholder type. At the 
highest level, parents can view a child’s vaccination record, add a vaccination record 
and view vaccination reports produced by the government. Since prototypes offer 
limited functionality (Houde & Hill, 1997), registering a child, E-mailing records and 
downloading records are not catered for.  
 
Figure 4.5: Overall process flows for Parents 
Figure 4.6 explains the process flows for the “Parent” stakeholder type included in e 
Vaccination in further detail.  
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ID Screenshot Description 
1a 
 
View child’s vaccination record - Parents can use their mobile 
phone or other devices to log into e-Vaccination and access 
their child’s vaccination records instead of searching for a 
physical vaccination record that might be misplaced. 
1b 
 
Select a child - e-Vaccination has child profiles loaded onto it 
to limit the amount of input required by the parents using this 
prototype. The child profiles appear in a dropdown menu that 
the parents can choose from. 
1c 
 
Display vaccination record - Once a child’s profile has been 
selected and the parent clicks on the “View records” button, the 
selected child’s vaccination record is displayed. The personal 
details of the child such as Name, ID Number, Date of birth, Age 
and Gender are displayed at the top of the page. This is followed 
by the details of vaccines administered to the child. 
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ID Screenshot Description 
2a 
 
Add a vaccination record - e-Vaccination allows parents to 
add a vaccination record to the selected child’s profile. 
2b 
 
Select a parent profile - The “Add a vaccination record” 
function within e-Vaccination has a “Parent profile” 
pre-populated dropdown menu that the parent can choose from. 
2c 
 
Select a child - Each parent profile contains a unique set of 
respective child profiles that the parent who is using 
e-Vaccination can select. 
2d 
 
Select vaccination and clinic - Once the child’s profile has 
been selected, the parent can then select the vaccine (based on 
the child’s age) as well as the clinic that the vaccine will be 
administered at. 
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ID Screenshot Description 
2e 
 
Add vaccination record - Once the parent clicks on “Add”, the 
vaccination record is successfully added to the child’s profile. 
3a 
 
View national reports - The National immunisation reports 
were made available in e-Vaccination as an added feature for 




Display national reports – National Immunisation coverage, 
Measles Immunisation 2nd dose - The reports displayed in the 
system are the National Immunisation coverage from 2012 to 
2017 as well as the Measles Immunisation (2nd dose) from 2012 
to 2017. 
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ID Screenshot Description 
4a 
 
View provincial reports - Provincial reports were made 
available in e-Vaccination as an added feature for purposes of 
making the information therein easily accessible to the parents. 
4b 
 
Select province - The provincial reports are displayed per 
province. The parent will have to select the province that he/she 
wishes to view and then click “Display”. 
4c 
 
Display provincial reports – Provincial Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Provincial Immunisation 
coverage from 2012 to 2017 as well as the Measles 
Immunisation (2nd dose) from 2012 to 2017 for the selected 
province. 
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ID Screenshot Description 
5a 
 
View local govt. reports - Local Government (District) reports 
were made available in e-Vaccination as an added feature for 




Select province and year - The Local Government reports are 
grouped by their respective provinces. The parent will select the 
province as well as the report year. 
5c 
 
Display District reports – District Immunisation coverage, 
Measles Immunisation 2nd dose - The reports displayed in the 
system are the Local Government (District) Immunisation 
coverage and the Measles Immunisation (2nd dose) for the 
districts based on the selected province and year. 




4.4.2 PROCESS FLOW: NURSES 
Figure 4.7 contains the overall processes that have been built for the Nurse 
stakeholder type. A nurse can view a child’s vaccination record (adding a record has 
been built with the view that parents will add the record) and view vaccination reports 
produced by the government. Verifying a vaccination record has not been built as part 
of the prototype.  
 
Figure 4.7: Overall process flows for Nurses 
Figure 4.8 details the process flows for the “Nurse” stakeholder type included in 









ID Screenshot Description 
1a 
 
View child’s vaccination record - Nurses can use their 
mobile phone or other devices to log into e-Vaccination and 
access a child’s vaccination records in the event that the 
physical vaccination record is not available. 
1b 
 
Select a child - e-Vaccination has child profiles loaded onto 
it to limit the amount of input required by the nurses using this 
prototype. The child profiles appear in a dropdown menu that 
the nurses can choose from. 
1c 
 
Display vaccination record - Once a child profile has been 
selected and the nurse clicks on the “View records” button, 
the selected child’s vaccination record is displayed. The 
personal details of the child such as Name, ID Number, Date 
of birth, Age and Gender are displayed at the top of the page, 
followed by details of the vaccines administered to the child. 
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ID Screenshot Description 
2a 
 
View national reports - The National immunisation reports 
were made available in e-Vaccination as an added feature 




Display national reports – National Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the National Immunisation 
coverage from 2012 to 2017 as well as the Measles 
Immunisation (2nd dose) from 2012 to 2017. 
3a 
 
View provincial reports - Provincial reports were made 
available in e-Vaccination as an added feature for purposes 
of making the information therein easily accessible to the 
nurses. 
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ID Screenshot Description 
3b 
 
Select province - The provincial reports are displayed per 
province. The nurse will have to select the province that 
he/she wishes to view and then click “Display”. 
3c 
 
Display provincial reports – Provincial Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Provincial Immunisation 
coverage from 2012 to 2017 as well as the Measles 




View local govt. reports - Local Government (District) 
reports were made available in e-Vaccination as an added 
feature for purposes of making the respective information 
easily accessible to the nurses. 
4b 
 
Select province and year - The Local Government reports 
are grouped by their respective provinces. The nurse will 
select the province as well as the report year. 
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ID Screenshot Description 
4c 
 
Display District reports – District Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Local Government (District) 
Immunisation coverage and the Measles Immunisation (2nd 
dose) for the districts, based on the selected province and 
year. 
Figure 4.8: Detailed process flows for Nurses 
4.4.3 PROCESS FLOW: DOCTORS 
Figure 4.9 depicts an overall process that has been built for the “Doctor” stakeholder 
type. A doctor can view a child’s vaccination record and view vaccination reports 
produced by the government. Verifying a vaccination record has not been built as part 
of the prototype.  
 
Figure 4.9: Overall process flows for Doctors 
Figure 4.10 explains the process flows for the “Doctor” stakeholder type included in 
e-Vaccination in further detail. 
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ID Screenshot Description 
1a 
 
View child’s vaccination record - Doctors can use their 
mobile phone or other devices to log into e-Vaccination and 
access a child’s vaccination records in the event that the 
physical vaccination record is not available. 
1b 
 
Select a child - e-Vaccination has child profiles loaded onto 
it to limit the amount of input required by the doctor using this 
prototype. The child profiles appear in a dropdown menu that 
the doctors can choose from. 
1c 
 
Display vaccination record - Once a child profile has been 
selected and the doctor clicks on the “View records” button, 
the selected child’s vaccination record is displayed. Personal 
details of the child such as Name, ID Number, Date of birth, 
Age and Gender are displayed at the top of the page, 
followed by details of the vaccines administered to this child. 
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ID Screenshot Description 
2a 
 
View national reports - The National immunisation reports 
were made available in e-Vaccination as an added feature 




Display national reports – National Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the National Immunisation 
coverage from 2012 to 2017 as well as the Measles 
Immunisation (2nd dose) from 2012 to 2017. 
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ID Screenshot Description 
3a 
 
View provincial reports - Provincial reports were made 
available in e-Vaccination as an added feature for purposes 
of making that information easily accessible to the doctors. 
3b 
 
Select province - The provincial reports are displayed per 
province. The doctor will have to select the province that 
he/she wishes to view and then click “Display”. 
3c 
 
Display provincial reports – Provincial Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Provincial Immunisation 
coverage from 2012 to 2017 as well as the Measles 
Immunisation (2nd dose) from 2012 to 2017 for the selected 
province. 
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ID Screenshot Description 
4a 
 
View local govt. reports - Local Government (District) 
reports were made available in e-Vaccination as an added 
feature for purposes of making the information therein easily 
accessible to the doctors. 
4b 
 
Select province and year - The Local Government reports 
are grouped by their respective provinces. The doctor will 
select the province as well as the report year. 
4c 
 
Display District reports – District Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Local Government (District) 
Immunisation coverage and the Measles Immunisation (2nd 
dose) for the Districts based on the selected province and 
year. 
Figure 4.10: Detailed process flows for Doctors  
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4.4.4 PROCESS FLOW: SCHOOL ADMINISTRATORS 
Figure 4.11 outlines the overall process that has been built for the “School 
Administrator” stakeholder type. A school administrator can request a child’s 
vaccination record on the system. Since the prototype has been built with limited 
functionality, the requesting of a child’s vaccination record does not require approval. 
The records are automatically displayed. The school administrator can also view 
vaccination reports produced by the government. 
 
Figure 4.11: Overall process flows for School Administrators 
Figure 4.12 explains the process flows for the “School Administrator” stakeholder type 
included in e-Vaccination in further detail.  
 
 91 
ID Screenshot Description 
1a 
 
Request a child’s vaccination record - School 
Administrators can use their mobile phone or other devices 
to log into e-Vaccination and access a child’s vaccination 
records in the event that the physical vaccination record is 
not available. For purposes of making the prototype easier to 
use, the School Administrator can request a child’s 
vaccination record. In a real-world scenario, a form of 
authentication would be used as follows: 
1. A School Administrator will enter a child’s ID number 
and request the record,  
2. A parent will then receive notification via E-mail, 
3. The parent will then either approve or decline the 
request from the School Administrator by clicking on 
the appropriate link, and 
4. The School Administrator will then receive the child’s 
vaccination record or a notification that the request 
was declined via E-mail. 
1b 
 
Select a child - e-Vaccination has child profiles loaded onto 
it to limit the amount of input required by the School 
Administrator using this prototype. Child profiles appear in a 




Display vaccination record - Once a child profile has been 
selected and the School Administrator clicks on the “View 
records” button, the selected child’s vaccination record is 
displayed. Personal details of the child such as Name, ID 
Number, Date of birth, Age and Gender are displayed at the 
top of the page, followed by details of the vaccines 
administered to this child. 
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ID Screenshot Description 
2a 
 
View national reports - The National immunisation reports 
were made available in e-Vaccination as an added feature 
for purposes of making the information easily accessible to 
the School Administrators. 
2b 
 
Display national reports – National Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the National Immunisation 
coverage from 2012 to 2017 as well as the Measles 
Immunisation (2nd dose) from 2012 to 2017. 
3a 
 
View provincial reports - Provincial reports were made 
available in e-Vaccination as an added feature for purposes 
of making the information easily accessible to the School 
Administrators. 
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ID Screenshot Description 
3b 
 
Select province - Provincial reports are displayed per 
province. The School Administrator will have to select the 
province that he/she wishes to view and then click “Display”. 
3c 
 
Display provincial reports – Provincial Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Provincial Immunisation 
coverage from 2012 to 2017 as well as the Measles 




View local govt. reports - Local Government (District) 
reports were made available in e-Vaccination as an added 
feature for purposes of making the information easily 
accessible to the School Administrators. 
4b 
 
Select province and year - Local Government reports are 
grouped by their respective provinces. The School 
Administrator will select the province as well as the report 
year. 
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ID Screenshot Description 
4c 
 
Display District reports – District Immunisation 
coverage, Measles Immunisation 2nd dose - The reports 
displayed in the system are the Local Government (District) 
Immunisation coverage and the Measles Immunisation (2nd 
dose) for the districts, based on the selected province and 
year. 
Figure 4.12: Detailed process flows for School Administrators 
4.5 RELEVANCE TO THE QUESTIONNAIRE 
The questionnaire (discussed in Section 3.5) was designed to collect data from the 
relevant stakeholders on their perceptions of e-Vaccination. Table 4.3 shows the 
association of the question from each category and the rationale behind the question. 
 
Table 4.3: Summary of the rationale behind the USE tool questions in the questionnaire 







The e-Vaccination application can help me to be more effective 
when handling vaccination records 
e-Vaccination allows for the stakeholder to log in and perform the same 
functions offered by paper-based vaccination cards. In addition to this, 
other functions such as viewing vaccination statistics is also possible. 
The e-Vaccination application can help me to be more productive 
when using the vaccination functions 
e-Vaccination could save you time by accessing the child’s profile even 
if the physical vaccination card is not available at that time. 
The e-Vaccination application is useful for managing vaccination 
records 
e-Vaccination allows the appropriate stakeholder to capture a 
vaccination at the time that it occurs. 
The e-Vaccination application will save me time when storing 
vaccination records 
Once the vaccination record has been saved, there is no need to safely 
store a physical card away. 
The e-Vaccination application will save me time when accessing 
vaccination records 
Since e-Vaccination is cloud based, a stakeholder can use a 
web-enabled device such as their mobile phone or desktop computer to 
access the child’s records instead of looking for the physical vaccination 
card which may result in someone having to physically go to a location 
where the card is stored.  
The e-Vaccination application meets my needs in terms of storing 
vaccination records 
The stakeholders can save a vaccination record which demonstrates 
how a record could be saved in an actual system. 
The e-Vaccination application saves my inputs as required Once a stakeholder saves a record, they are able to go into the child’s 
profile to verify whether the record was saved. 
The e-Vaccination application displays vaccination records in a 
way that I can understand 
The layout of the vaccination record of e-Vaccination differs from that of 






 The e-Vaccination application is easy to use e-Vaccination was aimed at being usable to stakeholders with varying 
degrees of experience with digital systems. 
The e-Vaccination application is not a complicated system to use If the complexity of using e-Vaccination is too high, the stakeholder 
adoption might be low. 
The e-Vaccination application is user friendly as it minimises the 
amount of input I need to enter 
e-Vaccination offers more drop-down options for entering information 
rather than expecting the stakeholder to input information via a textbox.  
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Category Question Rationale 
Any action on the e-Vaccination application is completed with the 
minimum number of possible steps 
e-Vaccination aims to reduce the number of steps and screen loads 
taken to perform a task.  
Using the e-Vaccination application is effortless Since many of the scenarios are story-based, the stakeholder can read 
the heading and instinctively determine which icon to click on next.  
I can use the e-Vaccination application without written instructions e-Vaccination aims to reduce the amount of help needed by a 
stakeholder to complete the required function.  
There are no inconsistencies within the e-Vaccination application e-Vaccination performs the functions expected by the stakeholders. 
I can recover from mistakes easily when using the e-Vaccination 
application 
If a stakeholder makes a mistake, they are able to go back and navigate 
to the function they required. 
I can use the e-Vaccination application successfully every time The stakeholder can use e-Vaccination consistently by performing 









I quickly understood how to use the e-Vaccination application e-Vaccination is a story and icon-based system allowing for the 
stakeholders to navigate to the required function easily by reducing the 
amount of learning needed. 
I easily remember how to use the e-Vaccination application The steps to perform different functions on e-Vaccination are similar. 
The stakeholders can use a function and then move to another function 
by remembering how the previous one worked. 
I quickly became skilful with the e-Vaccination application e-Vaccination promotes reduced time needed to perform functions as 
the stakeholder uses the system more often. 
I quickly learned how to navigate through the e-Vaccination 
application 
The menu of e-Vaccination is a central point to each stakeholder 
allowing them to move from menu to function and back to the menu. 
I quickly learned what the colour coding of the visual aids (icons) 
meant 
The use of a colour-based icon system differentiates between the 
functions that are offered by e-Vaccination and those that are concepts 
that could be incorporated into an actual system. The amber colour icons 











I am satisfied with the e-Vaccination application e-Vaccination meets the stakeholders’ expectations of an electronic 
vaccination record system. 
I would recommend the e-Vaccination application to a friend The adoption and popularity of such a system could increase with word 
of mouth distribution of the system. 
The e-Vaccination application works the way I want it to work e-Vaccination works correctly and performs all the available functions. 
I am satisfied with the overall appearance of the e-Vaccination 
application 
The colours and icons used in e-Vaccination are visually appealing to 
the stakeholder. 
I am satisfied with how the navigation of the e-Vaccination 
application works 
The stakeholder can navigate to different parts of the system without 












The use of visual aids (icons) are helpful when using the 
e-Vaccination application 
The visual aids limit the amount of reading required by the stakeholder. 
The icons appeal to the instinct of the stakeholder to click on the 
appropriate item. 
I would prefer written instructions on the e-Vaccination application 
instead of visual aids (icons) 
The stakeholder prefers more words to be used rather than visual aids.  
The visual aids (icons) help me navigate the e-Vaccination 
application easily 
The visual aids assist the stakeholder in finding the relevant function. 
The colour coding of the visual aids (icons) helps me to determine 
what the link means 
The amber and grey coloured icons assist the stakeholder in knowing 
which functions are available and which are not. 
The vaccination statistics provided are useful e-Vaccination offers historic statistics aimed at bringing at the relevant 
vaccination information closer to the stakeholder. 
 
 
Table 4.3 confirms the relevance of the question in the research instrument by 
identifying the feature of e-Vaccination that is relevant to that question.  
4.6 SUMMARY OF ARTEFACT 
Figure 4.13 shows the vaccination record systems and the Department of Health aims 
that influenced the design of e-Vaccination. The technical design, overall architecture, 
database field design, process flows, and functionality were taken into consideration 
when designing e-Vaccination. 
 
Figure 4.13: Summary of Chapter 4 
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CHAPTER 5: PRESENTATION OF RESULTS 
 
Figure 5.1: Structure of Chapter 5 
5.1 INTRODUCTION 
 
Figure 5.2: A recap of the data analysis steps that were followed 
Figure 5.2 above as discussed in Chapter 3 outlines the data analysis steps that were 
followed. In this chapter, the results of these data analysis steps are presented. The 
data collected from the research instrument is broken into 2 parts, these are 
demographic information and the scores from the USE tool. The demographic 
information has been presented in the form pie and bar charts. The USE tool part of 
the research instrument was used to determine the answer to the research question, 
“What are the perceptions of the key stakeholders towards replacing the paper-based 
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vaccination card with an electronic vaccination record system?” The perceptions were 
based on the following five categories that were introduced in Table 3.2: 
• Usefulness; 
• Ease of Use; 
• Ease of Learning; 
• Satisfaction; and 
• Design and Visual Aids. 
The results will be presented according to the following parameters: 
• Sample size; 
• Cronbach alpha; 
• Chi-Square test: 
o Critical value; 
o Chi-Square value displayed as an exponent; 
o Outcome (Whether Chi-Square value > or < critical value); and 
o Result (Reject or not reject the null hypothesis); 
• ANOVA: 
o F value; 
o p value; 
o f crit; 
o Significance; 
o Outcome of calculation; and 
o Result (Accept or reject the null hypothesis). 
• Principle Component Analysis 
o KMO value 
o Eigenvalues 
o Percentage contribution of factors 
5.2 DEMOGRAPHIC INFORMATION 
As mentioned in Chapter 3, responses to the research questionnaire were collected 
from four stakeholder types. These are parents, doctors, nurses and school 
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administration staff. This is due to their interaction with vaccinations and/or vaccination 
records.  
5.2.1 SECTION A OF THE RESEARCH INSTRUMENT 
There was a total of 118 respondents for the four stakeholder groups in a spread as 
depicted on the pie chart in Figure 5.3. All the respondents lived and/or worked in 
Gauteng. The questions asked in the questionnaire were whether respondents had 
access to a smartphone, Internet and Email addresses. 
 
Figure 5.3: Pie chart depicting the percentage responses per stakeholder type 
Of the 118 respondents to the questionnaire, 95% had access to a smartphone and at 
least 96% had Internet access. The breakdown of these responses by stakeholder 
type is provided in a bar chart in Figure 5.4 (smartphone access) and Figure 5.5 
(Internet access).  
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Figure 5.4: Bar chart depicting the number of respondents that have access to a smartphone versus 
those that did not have access to a smartphone, broken down by stakeholder type 
 
Figure 5.5: Bar chart depicting the number of respondents that have access to the Internet versus 
those that did not have access to the Internet, broken down by stakeholder type 
Figure 5.5 is a bar chart depiction of Internet access by stakeholder type. It was noted 
that 96% of the respondents had access to the Internet. 
Figure 5.6 is a bar chart depiction of participants that did or did not have an email 
address, shown by stakeholder type. It was noted that 96% of the respondents have 
an E-mail address. 
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Figure 5.6: Bar chart depicting the number of respondents that have an E-mail address versus those 
that did not have an E-mail address, broken down by stakeholder type 
5.2.2 SECTION B OF THE RESEARCH INSTRUMENT 
Section B of the questionnaire related to the respondent’s perceptions regarding 
vaccinations and vaccination record storage mechanisms in Gauteng. 
Approximately 91% of the respondents indicated that vaccination records in Gauteng 
are stored on the paper-based vaccination card. Perceptions on electronic systems 
storage was at 5%, while 3% were unsure about how vaccination records were stored 
and 1% indicated that no records were kept. Figure 5.7 shows the actual figures 
illustrated in a bar chart per stakeholder type. 
 
Figure 5.7: Bar chart depicting the responses to the vaccination storage medium used in Gauteng, 
broken down by stakeholder type 
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Experiences with a lost vaccination card or record was recorded by 47% of the 
respondents. For those who administer vaccinations and work closely with these 
records, that is, doctors and nurses, 94% indicated that they were aware of lost 
vaccination cards or records. Figure 5.8 is a bar chart that shows the breakdown by 
stakeholder type. 
 
Figure 5.8: Bar chart depicting the number of respondents that have experience with a lost vaccination 
card, broken down by stakeholder type 
For those stakeholders who have experience with a lost vaccination card, the 
measures that were taken to recover the lost vaccination records are provided in 
Figure 5.9. 
 
Figure 5.9: Pie chart depicting the percentage break down of the actions taken to retrieve the lost 
vaccination information 
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Of the 56 respondents who indicated that they had experienced a lost or damaged 
vaccination card, 52 selected an appropriate method taken to recover the lost 
information. Responses indicated that more than half (60%) of the lost records were 
obtained from a vaccination clinic. In other instances, a blood analysis would typically 
be done to recover records, as indicated by 17% of respondents while 23% indicated 
that records were recovered using other methods. Figure 5.10 is a bar chart that 
illustrates the breakdown by stakeholder type. 
 
Figure 5.10: Bar chart depicting the actions taken to retrieve the lost vaccination information, broken 
down by stakeholder type 
A free-text field was provided to allow the respondents to enter the steps taken to 
recover the information if the dropdown field provided did not contain a measure that 
they had taken. The “Other” measures are listed below: 
• History was never recovered, but we remembered what was given due to the 
structure order of the vaccines on the card; 
• Usually unable to obtain a record and rely on the mothers’ history; 
• Parent submitted a copy they had made; 
• Visiting the facility where the vaccinations had been done initially; 
• Parent went to the clinic to ask about another vaccination card with no luck; 
• Usually there is no way, unless a record was kept by the clinic; 
• Don't know what measures were taken to recover the lost detail; 
• We have to open new files for my child; 
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• Often the family try to get another Road to Health Booklet from the hospital 
where the child was born in my experience; 
• In the cases I witnessed, new records were given, and vaccinations continued 
from where mom said they had ended; and 
• Obtain duplicate card from local clinic. 
The safe and secure storage of vaccination records for minors in Gauteng should be 
the responsibility of the parents or guardians according to 69% of the respondents. 
The remaining 30% indicated that this should be the responsibility of government. 
Figure 5.11 reflects these responses and in Figure 5.12 a bar chart shows these 
responses by stakeholder type. 
 
Figure 5.11: Pie chart depicting the percentage breakdown of who should be responsible for storing 
minors’ vaccination records in Gauteng based on the stakeholders’ responses 
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Figure 5.12: Bar chart depicting who should be responsible for storing minors’ vaccination records in 
Gauteng, broken down by stakeholder type 
Figure 5.12 indicates that 52 parents, 14 doctors, 8 nurses and 8 school admin staff 
(82 in total) believe that parents and guardians should be responsible for the safe 
storage of vaccination records. The government should be responsible, according to 
21 parents, 2 doctors, 8 nurses and 4 school admin staff (35 in total). The remaining 
1 parent selected “not applicable.” 
Figure 5.13 is a pie chart that shows the stakeholders perceptions of whether minors 
in Gauteng receive their vaccinations on time and in Figure 5.14, a bar chart that 
illustrates the breakdown of these responses by stakeholder type is provided. 
 
Figure 5.13: Pie chart depicting the percentage break down of whether minors in Gauteng receive their 
vaccinations on time based on the stakeholders’ responses 
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Figure 5.14: Bar chart depicting the responses received regarding whether minors in Gauteng receive 
their vaccinations on time, broken down by stakeholder type 
Most of the respondents, 59%, believe that the paper-based vaccination card is a 
reliable way to store vaccination records. This question was however phrased in a 
negative way (indirectly favouring the physical vaccination card as a storage 
mechanism). Wording questions in this way can result in the respondents not reading 
the question well which poses problems with the responses, (Jozsa & Morgan, 2017).  
Figure 5.15 is a pie chart that illustrates the overall stakeholders’ perceptions of 
whether the paper-based vaccination card is a reliable way to store vaccination 





Figure 5.15: Pie chart depicting the percentage break down of whether the paper-based vaccination 
card is a reliable way to store vaccination records based on the stakeholders’ responses 
 
Figure 5.16: Bar chart depicting whether the paper-based vaccination card is a reliable way to store 
vaccination records, broken down by stakeholder type 
5.3 STATISTICAL ANALYSIS - SECTION C OF THE RESEARCH INSTRUMENT 
(USE TOOL) 
Section C of the questionnaire gathered responses regarding e-Vaccination. The 
questions were grouped into the categories: Usefulness, Ease of use, Ease of 
learning, Satisfaction and Design and visual aids as discussed in Chapter 3. The 
questions in each section were combined into composite values by calculating the 
mean values for each respondent. These values were then checked for reliability using 
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the Cronbach alpha which is a measure of reliability and internal consistency (Goforth, 
2015). The score for every category was greater than or equal to 0,67, higher than the 
recommended minimum of 0,65 (Goforth, 2015). 
5.3.1 RESULTS PERTAINING TO USEFULNESS 
The “Usefulness” section of the questionnaire was broken up into nine questions 
based on a 5-point Likert scale. These nine questions were combined into composite 
values by calculating their means. 
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,91 was obtained. Based on the Cronbach alpha scores and 
ratings in Table 3.5, this score has a rating of “excellent”. 
Chi-Square test 
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the “participants’ perceptions of the 
usefulness of e-Vaccination”. The related null hypothesis and alternate hypothesis 
were presented in Table 3.6. 
The frequency distribution table for the single variable Chi-Square calculation has 
been provided in Table 5.1. 
Table 5.1: Observed and expected frequencies for the usefulness category data  
Likert-scale options Observed Expected 
Strongly Agree 51 23,60 
Agree 61 23,60 
Neutral 6 23,60 
Disagree 0 23,60 
Strongly Disagree 0 23,60 
Total 118 118,00 
If the data for this category was completely random, as per H0- usefulness Chi-Square, then 
the number of responses for each option listed in Table 5.1 would have been equal 
and in this instance, would be approximately 23,60. These values were then used in 
the Chi-Square analysis. The results have been summarised in Table 5.2.  
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Table 5.2: Chi-Square results table for the usefulness category data  
Chi-Square value† 151,41 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 151,41† > 9,49‡ 
Result H0- usefulness Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The Chi-Square value for four degrees of freedom at a 5% level of significance was 
151,41. The critical Chi-Square value was 9,49; 151,41 > 9,49 which means that the 
difference between what we expected, and our observations was too great to be 
explained by chance alone. H0- usefulness Chi-Square is therefore rejected. Similarly, the p 
value was less than 0,001 for four degrees of freedom and a Chi-Square value of 
151,41 based on the Chi-Square f table. This means that the probability that random 
chance is causing the observed values to be different from the expected value is 
extremely small and we can conclude that the differences between the observed 
values and expected values are statistically significant.  
Analysis of Variance Test 
An ANOVA test was used to determine if the variances in the responses between the 
four stakeholder groups was statistically significant for the “Usefulness” category. The 
related null hypothesis and alternate hypothesis were presented in Table 3.7. 
Table 5.3 shows the detailed breakdown of responses by stakeholder type and Table 
5.4 a summary of the ANOVA calculations. 
Table 5.3: Summary of responses for the usefulness category by stakeholder type 
Stakeholder types Strongly 
agree 




Parents 35 36 3 0 0 
Doctors 4 10 2 0 0 
Nurses 6 9 1 0 0 
School Administrators 6 6 0 0 0 
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Table 5.4: Results of the ANOVA calculation for the usefulness category 
Sample size 118 
Cronbach alpha 0,91 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,48 
p value ¦ 0,23 
f crit 2,68 
Outcome of calculation 0,23¦ > 0,05§ 
Result H0- usefulness ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
“Usefulness” Category: Degrees of freedom (3†, 114‡) = 1,48; p value = 0,23 > 0,05 
(Not significant, since the p value is higher than the level of significance. H0- usefulness 
ANOVA is accepted). 
Result: The mean scores were not statistically different between the stakeholder 
groups. 
5.3.2 RESULTS PERTAINING TO EASE OF USE 
The “Ease of Use” section of the questionnaire was broken up into nine questions 
based on the 5-point Likert scale. These nine questions were combined into composite 
values by calculating the means. 
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,92 was obtained. Based on the Cronbach alpha scores and 
ratings in Table 3.5, this score has a rating of “excellent”. 
Chi-Square test 
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being “the participants’ perceptions of the 
ease of use of e-Vaccination”. The related null hypothesis and alternate hypothesis 
were previously presented in Table 3.6. 
The frequency distribution table for the single variable Chi-Square calculation has 
been provided in Table 5.5. 
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Table 5.5: Observed and expected frequencies for the ease of use category data 
Likert-scale options Observed Expected 
Strongly Agree 31 23,60 
Agree 75 23,60 
Neutral 10 23,60 
Disagree 2 23,60 
Strongly Disagree 0 23,60 
Total 118 118,00 
If the data for this category were completely random, as per H0- easy to use Chi-Square, then 
the number of responses for each option listed in Table 5.5 would have been equal, 
and this instance, approximately 23,60. These values were then used in the Chi-
Square analysis. The results have been summarised in Table 5.6. 
Table 5.6: Chi-Square results table for the ease of use category data  
Chi-Square value† 165,47 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 165,47† > 9,49‡ 
Result H0- easy to use Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The Chi-Square value for four degrees of freedom at a 5% level of significance was 
165,47. The critical Chi-Square value was 9,49; 165,47 > 9,49 which means that the 
difference between what we expected, and our observations was too great to be 
explained by chance alone. H0- easy to use Chi-Square is therefore rejected. Similarly, the p 
value was less than 0,001 for four degrees of freedom and a Chi-Square value of 
165,47 based on the Chi-Square f table. This means that the probability that random 
chance is causing the observed values to be different from the expected value is 
extremely small and we can conclude that the differences between the observed 
values and expected values are statistically significant.  
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Analysis of Variance Test 
An ANOVA test was used to determine if the variances in the responses between the 
four stakeholder groups was statistically significant for the “Ease of Use” category. 
The related null hypothesis and alternate hypothesis were previously presented in 
Table 3.7. 
Table 5.7 shows a detailed breakdown of responses by stakeholder type, followed by 
a summary of the ANOVA calculations in Table 5.8. 
Table 5.7: Summary of responses for the ease of use category by stakeholder type 
Stakeholder types Strongly 
agree 




Parents 19 47 7 1 0 
Doctors 2 12 2 0 0 
Nurses 6 9 0 1 0 
School administrators 4 7 1 0 0 
Table 5.8: Results of the ANOVA calculation for the ease of use category 
Sample size 118 
Cronbach alpha 0,92 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df freedom within groups ‡ 114 
F value 0,54 
p value ¦ 0,66 
f crit 2,68 
Outcome of calculation 0,66¦ > 0,05§ 
Result H0- easy to use ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
“Ease of Use” Category: Degrees of freedom (3†, 114‡) = 0,54; p value = 0,66 > 0,05 
(Not significant, since the p value is higher than the level of significance. H0- easy to use 
ANOVA is accepted). 
Result: The mean scores were not statistically different between the stakeholder 
groups. 
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5.3.3 RESULTS PERTAINING TO EASE OF LEARNING 
The “Ease of Learning” section of the questionnaire was broken up into five questions 
based on the 5-point Likert scale. These five questions were combined into composite 
values by calculating the means. 
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,9 was obtained. Based on the Cronbach alpha scores and 
ratings in Table 3.5, this score has a rating of “excellent”. 
Chi-Square test 
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the “participants’ perceptions of the 
ease of learning of e-Vaccination”. The related null hypothesis and alternate 
hypothesis were previously presented in Table 3.6. 
The frequency distribution table for the single variable Chi-Square calculation has 
been provided in Table 5.9. 
Table 5.9: Observed and expected frequencies for the ease of learning category data 
Likert-scale options Observed Expected 
Strongly Agree 33 23,60 
Agree 72 23,60 
Neutral 13 23,60 
Disagree 0 23,60 
Strongly Disagree 0 23,60 
Total 118 118,00 
If the data for this category was completely random, as per H0- easy to learn Chi-Square, then 
the number of responses for each option listed in Table 5.9 would have been equal 
and in this instance, approximately 23,60. These values were then used in the Chi-
Square analysis. The results have been summarised in Table 5.10.  
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Table 5.10: Chi-Square results table for the ease of learning category data  
Chi-Square value† 154,97 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 154,97 > 9,49‡ 
Result H0- easy to learn Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The Chi-Square value for four degrees of freedom at a 5% level of significance was 
154,97. The critical Chi-Square value was 9,49; 154,97 > 9,49 which means that the 
difference between what we expected, and our observations was too great to be 
explained by chance alone. H0- easy to learn Chi-Square is therefore rejected. Similarly, the p 
value was less than 0,001 for 4 degrees of freedom and a Chi-Square value of 154,97 
based on the Chi-Square f table. This means that the probability that random chance 
is causing the observed values to be different from the expected value is extremely 
small and we can conclude that the differences between the observed values and 
expected values are statistically significant.  
Analysis of Variance Test 
An ANOVA test was used to determine if the variances in the responses between the 
four stakeholder groups was statistically significant for the “Ease of Learning” 
category. The related null hypothesis and alternate hypothesis were presented in 
Table 3.7. 
Table 5.11 shows a detailed breakdown of responses by stakeholder type followed by 
a summary of the ANOVA calculations Table 5.12. 
Table 5.11: Summary of responses for the ease of learning category by stakeholder type 
Stakeholder types Strongly 
agree 




Parents 21 45 8 0 0 
Doctors 3 11 2 0 0 
Nurses 6 9 1 0 0 
School administrators 3 7 2 0 0 
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Table 5.12: Results of the ANOVA calculation for the ease of learning category 
Sample size 118 
Cronbach alpha 0,90 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 0,55 
p value ¦ 0,65 
f crit 2,68 
Outcome of calculation 0,65¦ > 0,05§ 
Result H0- easy to learn ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
“Ease of Learning” Category: Degrees of freedom (3†, 114‡) = 0,55; p value = 0,55 
> 0,05 (Not significant, since the p value is higher than the level of significance. H0- easy 
to learn ANOVA is accepted). 
Result: The mean scores were not statistically different between the stakeholder 
groups. 
5.3.4 RESULTS PERTAINING TO SATISFACTION 
The “Satisfaction” section of the questionnaire was broken up into five questions based 
on the 5-point Likert scale. These five questions were combined into composite values 
by calculating the means. 
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,90 was obtained. Based on the Cronbach alpha scores and 
ratings in Table 3.5, this score has a rating of “excellent”. 
Chi-Square test 
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the “participants’ perceptions of the 
satisfaction of e-Vaccination”. The related null hypothesis and alternate hypothesis 
were previously presented in Table 3.6. 
The frequency distribution table for the single variable Chi-Square calculation has 
been provided in Table 5.13. 
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Table 5.13: Observed and expected frequencies for the satisfaction category data 
Likert-scale options Observed Expected 
Strongly Agree 39 23,60 
Agree 64 23,60 
Neutral 14 23,60 
Disagree 1 23,60 
Strongly Disagree 0 23,60 
Total 118 118,00 
If the data for this category was completely random, as per H0- satisfaction Chi-Square, then 
the number of responses for each option listed in Table 5.13 would have been equal 
and approximately 23,60. These values were then used in the Chi-Square analysis. 
The results have been summarised in Table 5.14. 
Table 5.14: Chi-Square results table for the satisfaction category data  
Chi-Square value† 128,36 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 128,36† > 9,49‡ 
Result H0- satisfaction Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The Chi-Square value for four degrees of freedom at a 5% level of significance was 
128,36. The critical Chi-Square value was 9,49; 128,36 > 9,49 which means that the 
difference between what we expected, and our observations was too great to be 
explained by chance alone. H0- satisfaction Chi-Square is therefore rejected. Similarly, the p 
value was less than 0,001 for four degrees of freedom and a Chi-Square value of 
128,36 based on the Chi-Square f table. This means that the probability that random 
chance is causing the observed values to be different from the expected value is 
extremely small and we can conclude that the differences between the observed 
values and expected values are statistically significant. This result shows that H0- 
satisfaction could therefore not be rejected.  
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Analysis of Variance Test 
An ANOVA test was used to determine if the variances in the responses between the 
four stakeholder groups were statistically significant for the “Satisfaction” category. 
The related null hypothesis and alternate hypothesis were previously presented in 
Table 3.7. 
A detailed breakdown of responses by stakeholder type is provided in Table 5.15, 
followed by Table 5.16 with a summary of the ANOVA calculations. 









Parents 27 39 7 1 0 
Doctors 3 8 5 0 0 
Nurses 6 9 1 0 0 
School 
Administrators 
3 8 1 0 0 
Table 5.16: Results of the ANOVA calculation for the satisfaction category 
Sample size 118 
Cronbach alpha 0,90 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,54 
p value ¦ 0,21 
f crit 2,68 
Outcome of calculation 0,21¦ > 0,05§ 
Result H0- satisfaction ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
“Satisfaction” Category: Degrees of freedom (3†, 114‡) = 1,54; p value = 0,21 > 0,05 
(Not significant, since the p value is higher than the level of significance. H0- satisfaction 
ANOVA is accepted). 
Result: The mean scores were not statistically different between the stakeholder 
groups. 
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5.3.5 RESULTS PERTAINING TO DESIGN AND VISUAL AIDS 
The “Design and visual aids” section of the questionnaire was broken up into five 
questions based on the 5-point Likert scale. These five questions were combined into 
composite values by calculating the means. 
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,67 was obtained. Based on The Cronbach alpha scores and 
ratings from Table 3.5, this score has a rating of “questionable”. This lower score could 
have been the result of question 30 being worded in a negative way favouring written 
instructions over the use of visual aids. Some of the respondents might not have noted 
that the question was worded negatively when inserting their responses (Jozsa & 
Morgan, 2017). This could have negatively affected the outcome of this question 
therefore the results of this section could possibly have been higher. The score of 0,67 
is however higher than the recommended minimum of 0,65 (Goforth, 2015). 
Chi-Square test 
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the “participants’ perceptions of the 
design and visual aids in of e-Vaccination”. The related null hypothesis and alternate 
hypothesis were previously presented in Table 3.6. 
The frequency distribution table for the single variable Chi-Square calculation has 
been provided in Table 5.17. 
Table 5.17: Observed and expected frequencies for the design and visual aids category data 
Likert-scale options Observed Expected 
Strongly Agree 19 23,60 
Agree 78 23,60 
Neutral 18 23,60 
Disagree 3 23,60 
Strongly Disagree 0 23,60 
Total 118 118,00 
If the data for this category were completely random, as per H0- design and visual aids Chi-
Square, then the number of responses for each option listed in Table 5.17 would have 
been equal and in this instance, approximately 23,60. These values were then used 
in the Chi-Square analysis to give results as summarised in Table 5.18. 
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Table 5.18: Chi-Square results table for the design and visual aids category data  
Chi-Square value† 169,20 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 169,20† > 9,49‡ 
Result H0- design and visual aids Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The Chi-Square value for four degrees of freedom at a 5% level of significance was 
169,20. The critical Chi-Square value was 9,49; 169,20 > 9,49 which means that the 
difference between what we expected, and our observations was too great to be 
explained by chance alone. H0- design and visual aids Chi-Square is therefore rejected. Similarly, 
the p value was less than 0,001 for four degrees of freedom and a Chi-Square value 
of 169,20 based on the Chi-Square f table. This means that the probability that random 
chance is causing the observed values to be different from the expected value is 
extremely small and we can conclude that the differences between the observed 
values and expected values are statistically significant. This result shows that H0- design 
and visual aids could therefore not be rejected.  
Analysis of Variance Test 
An ANOVA test was used to determine if the variances in the responses between the 
four stakeholder groups was statistically significant for the “Design and Visual Aids” 
category. The related null hypothesis and alternate hypothesis were previously 
presented in Table 3.7. 
Table 5.19 shows a detailed breakdown of responses by stakeholder type followed by 
a summary of the ANOVA calculations in Table 5.20. 
Table 5.19: Summary of responses for the design and visual aids category by stakeholder type 
Stakeholder types Strongly 
agree 




Parents 10 56 6 2 0 
Doctors 1 10 5 0 0 
Nurses 7 5 3 1 0 
School Administrators 1 7 4 0 0 
Table 5.20: Results of the ANOVA calculation for the design and visual aids category 
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Sample size 118 
Cronbach alpha 0,67 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,45 
p value ¦ 0,23 
f crit 2,68 
Outcome of calculation 0,23¦ > 0,05 § 
Result H0- design and visual aids ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
“Design and Visual Aids” Category: Degrees of freedom (3†, 114‡) = 1,45; p value 
= 0,23 > 0,05 (Not significant, since the p value is higher than the level of significance. 
H0- design and visual aids ANOVA is accepted). 
Result: The mean scores were not statistically different between the stakeholder 
groups. 
5.3.6 DETERMINING THE PRINCIPLE FACTORS 
Section C of the questionnaire was designed to answer the research question “What 
are the perceptions of the key stakeholders towards replacing the paper-based 
vaccination card with an electronic vaccination record system?”  
To determine whether the responses to the 33 questions in this section of the 
questionnaire related to the five categories identified in Table 3.2 and the overall 
concept of digitising the vaccination card, a Principle Components Analysis (PCA) was 
performed. A PCA is a data reduction method which can reduce correlated variables 
into a few principle components (UCLA Institute for Digital Research & Education, 
2020). The outputs of this analysis are discussed below. The PCA calculations were 
done using XLSTAT version 2020.3.1.15. 
The Kaiser-Meyer-Olkin (KMO) Measure of Sampling Adequacy is used to determine 
whether the data is suitable to be used in a PCA (UCLA Institute for Digital Research 
& Education, 2020). The KMO value varies between 0 and 1 with a minimum 
suggested value of 0,6 (UCLA Institute for Digital Research & Education, 2020). The 
KMO value calculated was 0,91 and it is above the minimum recommended value. 
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The data were therefore suitable for the PCA. The specific results of the KMO can be 
found in Appendix 11. 
Eigenvalues were used to determine the main factors of the 33 questions. Generally, 
the factors with Eigenvalues greater than 1 should be kept (UCLA Institute for Digital 
Research & Education, 2020). These factors are considered significant and form the 
principle components of a dataset. The factors with Eigenvalues greater than 1 are 
displayed in Table 5.21. 
Table 5.21: Summary of the top six principle components as determined by the PCA 
Factors Eigenvalue Variability (%) Cumulative % 
1 16,93 51,30 51,30 
2 2,05 6,22 57,52 
3 1,78 5,38 62,91 
4 1,38 4,19 67,10 
5 1,22 3,69 70,79 
6 1,05 3,19 73,98 
From Table 5.21, it can be seen that almost 74% of the total variability of all the data 
collected related to these 6 factors. The variability of the remaining factors (7 to 33 
based on the 33 questions) can be seen in Appendix 12. These six factors had 
Eigenvalues greater than 1. The Eigenvalues were then plotted on a scree plot as 
shown in Figure 5.17. 
 
Figure 5.17: Scree plot showing all 33 identified factors from highest to lowest 
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The factor with the steepest gradient in the scree plot denotes the principle 
component. As seen from Figure 5.17, there is 1 principle factor (F1) which represents 
the overall concept of digitising the vaccination card.  
The remaining factors 2 to 6 though with gentler gradients, had Eigenvalues that were 
greater than 1. To determine which categories contributed to factors 2 to 6, a PCA was 
done on the composite values (the mean of the scores for each of the five categories). 
The results of the percentage contributions are given in Table 5.22.  
Table 5.22: Summary of the percentage category contributions to the five factors 
Categories F1 (%) F2 (%) F3 (%) F4 (%) F5 (%) 
Usefulness 18,608 17,457 60,125 3,225 0,584 
Ease of Use 23,421 0,000 9,301 3,367 63,911 
Ease of Learning 21,340 0,229 17,994 52,903 7,533 
Satisfaction 21,586 8,105 4,648 39,850 25,810 
Design and Visual Aids 15,045 74,208 7,931 0,654 2,162 
5.4 SUMMARY OF PRESENTATION OF RESULTS 
The responses to the demographic questions were displayed in the form of pie charts 
and bar charts where applicable. Table 5.23 is a summary of the responses. 
Table 5.23: Summary of the demographic results 
Stakeholder type Parents: 74 (62,7%) 
Doctors: 16 (13,6%) 
Nurses: 16 (13,6%) 
School administration staff: 12 (10,2%) 
Access to a smartphone Yes: 112 (95%) 
No: 6 (5%) 
Access to the Internet Yes: 113 (96%) 
No: 3 (2%) 
Not applicable: 2 (2%) 
Access to an E-mail address Yes: 113 (96%) 
No: 5 (4%) 
Perceptions towards vaccination storage in 
Gauteng 
Paper-based vaccination card: 108 (91%) 
Electronic systems: 5 (5%) 
No records are kept: 1 (1%) 
Not sure: 4 (3%) 
Experience with lost / damaged vaccination card Yes: 56 (47%) 
No: 62 (53%) 
Perceptions towards vaccination rates in 
Gauteng (vaccines are administered on time) 
Strongly agree: 16 (14%) 
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Agree: 49 (41%) 
Neither agree nor disagree: 30 (25%) 
Disagree: 20 (17%) 
Strongly disagree: 3 (3%) 
Perceptions towards the reliability of vaccination 
cards (vaccination cards are reliable) 
Strongly agree: 10 (8%) 
Agree: 25 (21%) 
Neither agree nor disagree: 14 (12%) 
Disagree: 41 (35%) 
Strongly disagree: 28 (24%) 
The responses to the USE tool section of the questionnaire were grouped by category 
based on the five sections (usability, ease of use, ease of learning, satisfaction and 
design and visual aids) and were analysed as composite values. The data were 
checked for reliability using the Cronbach alpha. A PCA was then done to confirm that 
the principle factor matched the research question. The data were then analysed using 
a Chi-Square test, Analysis of Variance test and a Principle Component Analysis. 
Table 5.24 is a summary of the results of the statistical analysis 
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Table 5.24: Summary of the statistical analysis 
Statistics Usefulness Ease of Use Ease of Learning Satisfaction Design and Visual 
Aids 
Data Reliability 
Cronbach alpha 0,91 0,92 0,9 0,9 0,67 
Chi-Square test 
Chi-Square value † 151,41 165,47 154,97 128,36 169,20 
df 4 4 4 4 4 
Critical Chi-Square 
value ‡ 
9,49 9,49 9,49 9,49 9,49 
Approximate p value <0,001 <0,001 <0,001 <0,001 <0,001 
Alpha value 0,05 0,05 0,05 0,05 0,05 
Outcome of calculation 151,41† > 9,49‡ 165,47† > 9,49‡ 154,97† > 9,49‡ 128,36† > 9,49‡ 169,20† > 9,49‡ 
Result H0- usefulness Chi-Square 
Rejected 
H0- easy to use Chi-Square 
Rejected 
H0- easy to learn Chi-Square 
Rejected 
H0- satisfaction Chi-Square 
Rejected 
H0- design and visual aids Chi-
Square Rejected 
ANOVA test 
Alpha value § 0,05 0,05 0,05 0,05 0,05 
df between groups 3 3 3 3 3 
df within groups 114 114 114 114 114 
F value 1,48 0,54 0,55 1,54 1,45 
p value ¦ 0,23 0,66 0,65 0,21 0,23 
f crit 2,68 2,68 2,68 2,68 2,68 
Outcome of calculation 0,23¦ > 0,05§ 0,66¦ > 0,05§ 0,65¦ > 0,05§ 0,21¦ > 0,05§ 0,23¦ > 0,05 § 
Result H0- usefulness ANOVA 
Accepted 
H0- easy to use ANOVA 
Accepted 
H0- easy to learn ANOVA 
Accepted 
H0- satisfaction ANOVA 
Accepted 
H0- design and visual aids ANOVA 
Accepted 
Principle Component Analysis 
Contribution to Factor 1 18,6 23,4 21,3 21,6 15,1 
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Contribution to Factor 2 17,5 0,0 0,2 8,1 74,2 
Contribution to Factor 3 60,1 9,3 18,0 4,7 7,9 
Contribution to Factor 4 3,2 3,4 52,9 39,9 0,7 
Contribution to Factor 5 0,6 63,9 7,5 25,8 2,2 
Overall 
Result H0- usefulness Accepted H0- easy to use Accepted H0- easy to learn Accepted H0- satisfaction Accepted H0- design and visual aids 
Accepted 
† Chi-Square value 
‡ Critical Chi-Square value 
§ Alpha value 
¦ p value 
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In this chapter, the responses to the questionnaire were analysed and presented. In 
the following chapter (Discussion of results), the results will be interpreted. These 
interpretations will lead up to the conclusion. 
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CHAPTER 6: DISCUSSION OF RESULTS 
 
Figure 6.1: Structure of Chapter 6 
6.1 INTRODUCTION 
The results obtained from the previous chapter (the Cronbach Alpha, Chi-Square test, 
ANOVA test and the Principle Component Analysis test) are summarised in Figure 
6.2 and will be interpreted in this chapter. In the next section, the results of the data 
analysis are summarised. 
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Figure 6.2: Summary of the data analysis results for each step as per Chapter 5 
6.2 ANALYSIS OF THE DATA 
The outcomes of the Cronbach alpha, Chi-Square, ANOVA and PCA tests will be 
discussed in the sections that follow.  
6.2.1 OUTCOMES OF THE CRONBACH ALPHA TEST 
The Cronbach alpha is used to determine the reliability of a set of questions (Goforth, 
2015). Cronbach alpha scores are expressed as a decimal value from 0 to 1 (Goforth, 
2015). The scores are interpreted according to the Cronbach alpha scores and ratings 
that were provided in Table 3.5.  
The Cronbach Alpha test was run on the composite scores of the five categories 
yielding the following results (rounded off to 2 decimal places): 
Table 6.1: Summary of the Cronbach Alpha scores per category 
Category Score Comment 
Usefulness 0,91 Excellent as per Table 3.5 
Ease of Use 0,92 Excellent as per Table 3.5 
Ease of Learning 0,90 Excellent as per Table 3.5 
Satisfaction 0,90 Excellent as per Table 3.5 
Design and Visual 
Aids 
0,67 Questionable according to Table 3.5 but still above the 
recommended minimum of 0,65 
The results of the Cronbach alpha showed that data that was collected from the 
questionnaire was reliable and could then be analysed further.  
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6.2.2 OUTCOMES OF THE CHI-SQUARE TEST 
The Chi-Square test is used to determine the likelihood that an observed distribution 
of categorical data is due to chance (University of Pennsylvania School of Arts and 
Sciences, 2008). To ensure that that the data collected from the questionnaire was 
not due to a random occurrence and was instead related to a variable, a Chi-Square 
test was performed. This test was run on the composite scores of the five categories 
yielding the following results in Table 6.2. 
Table 6.2: Summary of the Chi-Square test outcome per category 
Category Outcome Comment 
Usefulness H0- usefulness Chi-Square rejected Data was not random 
Ease of Use H0- easy to use Chi-Square rejected Data was not random 
Ease of Learning H0- easy to learn Chi-Square rejected Data was not random 
Satisfaction H0- satisfaction Chi-Square rejected Data was not random 
Design and Visual Aids H0- design and visual aids Chi-Square rejected Data was not random 
The results of the Chi-Square test showed that the data that was collected from the 
questionnaire was not random. 
6.2.3 OUTCOMES OF THE ANALYSIS OF VARIANCE TEST 
Once it was established that the data was reliable and not random, the ANOVA test 
was run. The analysis of variance test was used as data was collected from more than 
two stakeholder types. The ANOVA test is used to determine if there are significant 
differences between different experimental conditions (Rutherford, 2000). This test 
compared the mean scores across the four stakeholder groups for each category to 
determine if the null hypothesis for each sub-category was accepted. The results of 
the ANOVA test are summarised in Table 6.3. 




Usefulness H0- usefulness ANOVA 
accepted 
No statistical difference between the mean scores of 
the 4 stakeholder groups 
Ease of Use H0- easy to use ANOVA 
accepted 
No statistical difference between the mean scores of 
the 4 stakeholder groups 
Ease of 
Learning 
H0- easy to learn ANOVA 
accepted 
No statistical difference between the mean scores of 
the 4 stakeholder groups 
Satisfaction H0- satisfaction ANOVA 
accepted 
No statistical difference between the mean scores of 







H0- design and visual aids ANOVA 
accepted 
No statistical difference between the mean scores of 
the 4 stakeholder groups 
At this point it was determined that, in addition to the data being reliable and not 
random, the mean scores between the stakeholder groups for each category were not 
statistically different indicating that they had the same perceptions.  
6.2.4 OUTCOMES OF THE PRINCIPLE COMPONENT ANALYSIS TEST 
The questionnaire was created based on an adaptation of the USE tool as mentioned 
in Chapter 3. The four categories of the USE tool, that is, usefulness, ease of use, 
ease of learning and satisfaction were included. A fourth category called design and 
visual aids was added to the questionnaire. This category was added due to a new 
dimension of applications such as e-Vaccination as well as the other applications 
mentioned in Chapter 2. These applications have a graphically focussed user interface 
that helps to drive the functions of the application. The five categories were then 
manually added to the questionnaire under their respective headings.  
The PCA was conducted on the entire dataset of all 118 participants to the 33 
questions contained in Section C of the questionnaire. A PCA which is a data reduction 
method (UCLA Institute for Digital Research & Education, 2020) can be used to 
investigate the relationship between dependent variables (Syms, 2019). The PCA was 
used to determine whether the stakeholders’ responses were related to the overall 
research question relating to the digitisation of the vaccination card. The PCA was 
also used to determine the factors relating to the 5 sub-categories of the questionnaire 
viz. usefulness, ease of use, ease of learning, satisfaction and design and visual aids. 
The PCA calculations were done using XLSTAT version 2020.3.1.15. 
Prior to conducting the PCA, the Kaiser-Meyer-Olkin (KMO) value was calculated to 
determine whether the data was suitable for a PCA, since the KMO value is a measure 
of sampling adequacy (UCLA Institute for Digital Research & Education, 2020). The 
KMO value should be greater than 0,5 (David & Jacobs, 2014). The KMO value was 
calculated as 0,91 which is above the minimum recommended value. The data was 
therefore suitable for a PCA. 
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Eigenvalues were used to determine the main factors of the 33 questions. Generally, 
the factors with Eigenvalues greater than 1 should be kept (UCLA Institute for Digital 
Research & Education, 2020). These factors are considered significant and form the 
principle components of the dataset. The factors with Eigenvalues greater than 1 and 
can be referred to in Table 5.21 with an accompanying scree plot in Figure 5.17. The 
results reflected that the responses of the stakeholders were related to the research 
question relating to the digitisation of the vaccination card.  
The remaining factors 2 to 6, though with gentler gradients, had Eigenvalues that were 
greater than 1. To determine which categories contributed to factors 2 to 6, a PCA was 
then run on the composite values of the 5 categories. From this, 5 factors were 
identified. The percentage contributions of the categories to these factors helped to 
determine what these 5 underlying factors related to. Figure 6.3 is a graphical 
summary of the percentage contributions of each of the five categories as determined 
by a PCA, across five factors (as previously captured in Table 5.22), as well as the 
main contributors to those factors. 
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Figure 6.3: The percentage contributions of the categories towards the five factors identified by the 
PCA and the majority factor contributions of each category 
The percentage contributions towards the factors then led to the naming of the factors 
as listed below; 
• Factor 1 à User friendliness 
• Factor 2 à Graphical design 
• Factor 3 à Practicality 
• Factor 4 à User experience 
• Factor 5 à Usability 
The interpretations relating to each of the five categories are discussed below.  
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6.3 DISCUSSION PERTAINING TO USEFULNESS 
The nine questions from the “Usefulness” category were combined to form composite 
values (calculated as the mean score) to aid in understanding the overall perception 
of this category.  
A score of 0,91, according to the Cronbach Alpha scores in Table 6.1 has a rating of 
“excellent”. This score showed that data that was collected from the questionnaire was 
reliable and could be further analysed.  
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable. The related null hypothesis and alternate 
hypothesis are presented below 
Table 6.4: The null and alternate hypotheses for the Chi-Square test for the usefulness category 
Null 
Hypothesis 






The proportions of scores for 
the usefulness category are the 
same between the observed 
and the expected responses 
H1- usefulness Chi-
Square 
At least 2 proportions of scores 
for the usefulness category are 
different between the observed 
and the expected responses 
The results of the Chi-Square test were provided in Table 5.2, reproduced below. 
Table 5.2: Chi-Square results table for the usefulness category data  
Chi-Square value† 151,41 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 151,41† > 9,49‡ 
Result H0- usefulness Chi-Square rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The results of the Chi-Square test showed that the data that was collected from the 
questionnaire for the usefulness category was not random. 
Once it was determined that the data collected for this category was reliable and not 
random, the ANOVA test was run. The ANOVA test was used to determine if the 
variances in the responses between the 4 stakeholder groups was statistically 
significant for the usefulness category. The related null hypothesis and alternate 
hypothesis are presented below. 
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Table 6.5: The null and alternate hypotheses for the ANOVA test for the usefulness category 
Null 
Hypothesis 






The mean scores for the 
usefulness category across the 




At least 2 mean scores for the 
usefulness category across the 
4 stakeholder groups are 
different 
Table 5.4 which has been reproduced below is a summary of the ANOVA calculations 
for the usefulness category. 
Table 5.4: Results of the ANOVA calculation for the usefulness category 
Sample size 118 
Cronbach alpha 0,91 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,48 
p value ¦ 0,23 
f crit 2,68 
Outcome of calculation 0,23¦ > 0,05§ 
Result H0- usefulness ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
Subsequent ANOVA tests showed that the mean scores between the stakeholder 
groups for the usefulness category were not statistically different. This meant that the 
four stakeholder groups shared common perceptions towards the usefulness of e-
Vaccination. 
The PCA was then run on the composite values of the usefulness category. From this, 
five factors were identified. The percentage contributions of the usefulness category 
towards the five factors as identified by the PCA are depicted in Figure 6.4. 
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Figure 6.4: The percentage contributions of the usefulness category towards the five factors identified 
by the PCA  
The PCA demonstrated that there was a 60,1% contribution of the usefulness category 
towards Factor 3, this was previously labelled in Section 6.2.4 as “Practicality”. In other 
words, for e-Vaccination to be adopted by key stakeholders, the system would need 
to be practical. The system would need to provide all of the current functionality of the 
paper-based vaccination card at the minimum and provide additional benefits where 
possible. During a clinic visit, the nurses were impressed by the vision of the system 
as well as its practicality. It was noted however that e-Vaccination did not contain all 
the data fields that are required for the creation of a vaccination record. These fields 
were the “batch number” and “expiry date” of the vaccine being administered. This is 
not a major concern as these two data fields can be easily added later on. Many of the 
nurses could see how a system of this nature would be useful to them. Many asked, 
“When will the system be ready for us to use?”  
From the parents’ perspective, it was discussed in Chapter 2 that the loss of a paper-
based vaccination card is a threat to these records. e-Vaccination being a digital 
platform, can give parents access to these records without having to locate the 
physical card. A new dimension can be considered for doctors as well as school 
administrators who may want access to these records. Based on the design, school 
administrators could request the records from the parents and doctors could access 
the records themselves. In Chapter 2, the Measles outbreak in Gauteng during 2017 
was mentioned. Another potential use of e-Vaccination is related to the mining of 
digital data. Having real-time information on vaccination coverage at an individual child 
level could give key decision makers enough information to form an effective strategy 
during times of such pandemics. These features, some of which are not possible with 
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the paper-based vaccination card contribute to the usefulness and practicality of e-
Vaccination.  
Figure 6.5 is a radar chart that shows the mean weighted scores (expressed as a 
percentage) of the responses for all the stakeholder types related to the usefulness 
category.  
 
Figure 6.5: Mean weighted scores (expressed as a percentage) amongst the four stakeholder groups 
for the usefulness category 
Figure 6.5 above graphically represents the responses related to the usefulness 
category. The weighted percentage scores per stakeholder group and the average 
weighted percentage score are detailed in Table 6.6. 
Table 6.6: Mean weighted scores per stakeholder group for the usefulness category (expressed as a 
percentage) 
Parents Doctors Nurses School admin Average weighted percentage 
89% 83% 86% 90% 87% 
The average weighted percentage score for this category was 87%. The average 
weighted percentage score was converted from a weighted average score of 4,38 out 
of 5,00 on the 5-point Likert scale that was used in the questionnaire. This score falls 
within the “Agree” range of the Likert scale. According to these results, the statistical 
analysis and interpretations, it is clear that e-Vaccination was found to be useful. 
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6.4 DISCUSSION PERTAINING TO EASE OF USE 
The nine questions from the “Ease of use” category were combined to form composite 
values (calculated as the mean score) to aid in understanding the overall perception 
of this category.  
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,92 was obtained and based on Cronbach alpha scores and 
ratings listed previously in Table 3.5, this score has a rating of “excellent” (>0.9). This 
score showed that the data that was collected from the questionnaire was reliable and 
could be further analysed.  
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the “participants’ perceptions of the 
ease of use of e-Vaccination”. The related null hypothesis and alternate hypothesis 
are presented below: 
Table 6.7: The null and alternate hypotheses for the Chi-Square test for the ease of use category 
 Null 
Hypothesis 




H0- easy to use 
Chi-square 
The proportions of scores for 
the ease of use category are 
the same between the 
observed and the expected 
responses 
H1- easy to use Chi-
square 
At least 2 proportions of scores 
for the ease of use category are 
different between the observed 
and the expected responses 
The results of the Chi-square test have been summarised in Table 5.6 which has been 
reproduced below. 
Table 5.6: Chi-square results table for the ease of use category data  
Chi-Square value† 165,47 
df 4 
Critical Chi-Square value based on the Chi-Square f 
table‡ 
9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 165,47† > 9,49‡ 
Result H0- easy to use Chi-Square Rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The results of the Chi-Square test showed that the data that was collected from the 
questionnaire for the ease of use category was not random. 
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Once it was determined that the data collected for this category was reliable and not 
random, the ANOVA test was run. The ANOVA test was used to determine if the 
variances in the responses between the 4 stakeholder groups was statistically 
significant for the ease of use category. The related null hypothesis and alternate 
hypothesis are presented below. 
Table 6.8: The null and alternate hypotheses for the ANOVA test for the ease of use category 
Null 
Hypothesis 




H0- easy to use 
ANOVA 
The mean scores for the ease 
of use category across the 4 
stakeholder groups are the 
same 
H1- easy to use 
ANOVA 
At least 2 mean scores for the 
ease of use category across the 4 
stakeholder groups are different 
Table 5.8 reproduced below is a summary of the ANOVA calculations for the ease of 
use category. 
Table 5.8: Results of the ANOVA calculation for the ease of use category 
Sample size 118 
Cronbach alpha 0,92 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df freedom within groups ‡ 114 
F value 0,54 
p value ¦ 0,66 
f crit 2,68 
Outcome of calculation 0,66¦ > 0,05§ 
Result H0- easy to use ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
The result of the ANOVA test shows that the mean scores between the stakeholder 
groups for the “Ease of Use” category were not statistically different. This meant that 
the four stakeholder groups shared common perceptions towards the ease of use of 
e-Vaccination. 
The PCA was then run on the composite values of the “Ease of Use” category. From 
this, five factors were identified. The percentage contributions of the “Ease of Use” 
category towards the five factors identified by the PCA are depicted in Figure 6.6.  
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Figure 6.6: The percentage contributions of the ease of use category towards the five factors identified 
by the PCA  
The PCA showed that the “Ease of Use” category contributed 63,9% towards Factor 
five, this was labelled in Section 6.2.4 as “Usability”. For a system of this nature with 
user groups who could vary in their experience with digital technologies, the system 
needs to be easy to use. The users would need to instinctively know where to go to 
complete their specific task. There were no incidents where the stakeholders 
requested assistance to fulfil a task.  
Figure 6.7 is a graphical representation of the mean weighted scores (expressed as 
a percentage) for the “Ease of Use” category for the four stakeholder groups. The 
weighted percentage scores per stakeholder group and the average weighted 
percentage score are further detailed in Table 6.9. 
 
Figure 6.7: Mean weighted scores (expressed as a percentage) amongst the four stakeholder groups 
for the ease of use category 
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Table 6.9: Mean weighted scores per stakeholder group for the ease of use category (expressed as a 
percentage) 
Parents Doctors Nurses School admin Average weighted percentage 
83% 80% 85% 85% 83% 
The average weighted percentage score for this category was 83%. The average 
weighted percentage score was converted from a weighted average score of 4,14 out 
of 5,00 on the 5-point Likert scale that was used in the questionnaire. This score falls 
within the “Agree” range of the Likert scale. The outcome of the statistical analysis and 
the fact that no assistance was required by the stakeholders in using the application, 
show that e-Vaccination was easy to use. 
6.5 DISCUSSION PERTAINING TO EASE OF LEARNING 
The five questions from the “Ease of Learning” category were combined to form 
composite values (calculated as the mean score) to aid in understanding the overall 
perception of this category.  
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,90 was obtained and based on the Cronbach alpha scores and 
ratings previously listed in Table 3.5, this score has a rating of “good” (>0,8 alpha 
<=0,9). This score shows that the data that was collected from the questionnaire was 
reliable and could be further analysed.  
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the participants’ perceptions of the 
ease of learning of e-Vaccination. The related null hypothesis and alternate hypothesis 
are presented below: 
Table 6.10: The null and alternate hypotheses for the Chi-Square test for the ease of learning category 
 Null 
Hypothesis 




H0- easy to learn 
Chi-Square 
The proportions of scores for 
the ease of learning category 
are the same between the 
observed and the expected 
responses 
H1- easy to learn 
Chi-Square 
At least 2 proportions of scores 
for the ease of learning category 
are different between the 
observed and the expected 
responses 
The results of the Chi-Square test have been summarised in Table 5.10 which has 
been reproduced below. 
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Table 5.10: Chi-Square results table for the ease of learning category data  
Chi-Square value† 154,97 
df 4 
Critical Chi-Square value based on the Chi-Square f 
table‡ 
9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 154,97 > 9,49‡ 
Result H0- easy to learn Chi-Square Rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The results of the Chi-Square test showed that the data that was collected from the 
questionnaire for the ease of learning category was not random. 
Once it was determined that the data collected for this category was reliable and not 
random, an ANOVA test was run.  
The ANOVA test was used to determine if the variances in the responses between the 
4 stakeholder groups was statistically significant for the ease of learning category. The 
related null hypothesis and alternate hypothesis are presented below. 
Table 6.11: The null and alternate hypotheses for the ANOVA test for the ease of learning category 
Null 
Hypothesis 




H0- easy to learn 
ANOVA 
The mean scores for the 
ease of learning category 
across the 4 stakeholder 
groups are the same 
H1- easy to learn 
ANOVA 
At least 2 mean scores for the 
ease of learning category 
across the 4 stakeholder 
groups are different 
Table 5.12 reproduced below is a summary of the ANOVA calculations for the ease 
of learning category. 
Table 5.12: Results of the ANOVA calculation for the ease of learning category 
Sample size 118 
Cronbach alpha 0,90 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 0,55 
p value ¦ 0,65 
f crit 2,68 
Outcome of calculation 0,65¦ > 0,05§ 
Result H0- easy to learn ANOVA Accepted 
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§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
The related null hypothesis and alternate hypothesis for the ANOVA test were 
provided in Table 3.7 and the results of the ANOVA test showed that the mean scores 
between the stakeholder groups for the “Ease of Learning” category were not 
statistically different. This meant that the four stakeholder groups shared common 
perceptions towards the “Ease of Learning” of e-Vaccination. 
A PCA was then run on the composite values of the “Ease of Learning” category. From 
this, five factors were identified. The percentage contributions of the “Ease of 
Learning” category towards the five factors identified by the PCA are depicted in 
Figure 6.8. 
 
Figure 6.8: The percentage contributions of the ease of learning category towards the five factors 
identified by the PCA  
The PCA test showed that this category contributed 52,9% towards Factor 4, this 
factor was labelled in Section 6.2.4 as “User experience”. Due to the nature of 
vaccination records, medical staff such as doctors and nurses would need to create 
and access vaccination records more frequently than parents and school 
administrators would. The latter groups generally access these records only at certain 
times of the year or during a child’s development. The vision of the system is that it 
should be possible for stakeholders to use the system without any formal training. The 
system therefore needs to be easy to learn. Once logged into e-Vaccination, each 
stakeholder group was directed to the area of the system relevant for them. A 
“conversational style” navigation was used, putting the stakeholder at the centre of the 
required function. A parent would, as an example, select “I am a Parent” and “I want 
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to view a vaccination record”. This style of navigation required no formal training for 
the stakeholders. There were also no “helpful hints” provided, meaning that the 
navigation text and graphics served as the only help offered. 
Figure 6.9 is a graphical representation of the overall mean weighted scores 
(expressed as a percentage) for the “Ease of Learning” category. 
 
Figure 6.9: Mean weighted scores (expressed as percentage) amongst the 4 stakeholder groups for 
the ease of learning category 
The weighted percentage scores per stakeholder group and the average weighted 
percentage score are detailed in Table 6.12. 
Table 6.12: Mean weighted scores per stakeholder group for the ease of learning category (expressed 
as a percentage) 
Parents Doctors Nurses School admin Average weighted percentage 
84% 81% 86% 82% 83% 
The average weighted percentage score for this category was 83%. The average 
weighted percentage score was converted from a weighted average score of 4,17 out 
of 5,00 on the 5-point Likert scale that was used in the questionnaire. This score falls 
within the “Agree” range of the Likert scale. The statistical analysis shows that the 
stakeholders agreed that e-Vaccination was easy to learn and offered a good user 
experience. 
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6.6 DISCUSSION PERTAINING TO SATISFACTION 
The five questions from the “Satisfaction” category were combined to form composite 
values (calculated as the mean score) to aid in understanding the overall perception 
of this category.  
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,90 was obtained and based on the Cronbach alpha scores and 
ratings in Table 3.5, this score has a rating of “good” (>0,8 alpha <=0,9). This score 
shows that the data that was collected from the questionnaire was reliable and could 
then be analysed.  
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the participants’ level of satisfaction 
with e-Vaccination. The related null hypothesis and alternate hypothesis are presented 
below: 
Table 6.13: The null and alternate hypotheses for the Chi-Square test for the satisfaction category 
Null 
Hypothesis 






The proportions of scores for 
the satisfaction category are the 
same between the observed 
and the expected responses 
H1- satisfaction Chi-
Square 
At least 2 proportions of scores 
for the satisfaction category are 
different between the observed 
and the expected responses 
The results of the Chi-Square test have been summarised in Table 5.14 which has 
been reproduced below. 
Table 5.14: Chi-Square results table for the satisfaction category data  
Chi-Square value† 128,36 
df 4 
Critical Chi-Square value based on the Chi-Square f table‡ 9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 128,36† > 9,49‡ 
Result H0- satisfaction Chi-Square Rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The results showed that data that was collected from the questionnaire for the 
“Satisfaction” category was not random. 
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Once it was determined that the data collected for this category was reliable and not 
random, the ANOVA test was run. The ANOVA test was used to determine if the 
variances in the responses between the 4 stakeholder groups was statistically 
significant for the satisfaction category. The related null hypothesis and alternate 
hypothesis are presented below. 
Table 6.14: The null and alternate hypotheses for the ANOVA test for the satisfaction category 
 Null 
Hypothesis 






The mean scores for the 
satisfaction category across the 




At least 2 mean scores for the 
satisfaction category across the 
4 stakeholder groups are 
different 
Table 5.16 reproduced below is a summary of the ANOVA calculations for the 
satisfaction category. 
Table 5.16: Results of the ANOVA calculation for the satisfaction category 
Sample size 118 
Cronbach alpha 0,90 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,54 
p value ¦ 0,21 
f crit 2,68 
Outcome of calculation 0,21¦ > 0,05§ 
Result H0- satisfaction ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
The result of the ANOVA test showed that the mean scores between the stakeholder 
groups for the “Satisfaction” category were not statistically different. This meant that 
the four stakeholder groups were satisfied with e-Vaccination. 
A PCA was then run on the composite values of the “Satisfaction” category. From this, 
five factors were identified. The percentage contributions of the “Satisfaction” category 
towards the five factors identified by the PCA are depicted in Figure 6.10. 
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Figure 6.10: The percentage contributions of the satisfaction category towards the five factors identified 
by the PCA  
The PCA test showed that this category contributed 39,9% towards Factor 4, this 
factor was labelled in Section 6.2.4 as “User experience”. The “Ease of Learning” 
category also had a major proportion of its contribution towards Factor 4. It can 
therefore be deduced that the ability of the stakeholder in learning how to use e-
Vaccination is related to their satisfaction with e-Vaccination. It was mentioned under 
the “Ease of Use” discussion that none of the stakeholders requested assistance with 
completion of any task. If the stakeholder wanted to complete a task such as to view 
a vaccination record, they probably easily navigated to that function and viewed the 
results that they intended to see. This may have given the stakeholder a sense of 
satisfaction for completing the task they had set out to do. 
Figure 6.11 is a radar chart that shows the mean weighted scores (expressed as a 
percentage) per stakeholder group.  
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Figure 6.11: Mean weighted scores (expressed as a percentage) amongst the four stakeholder groups 
for the satisfaction category 
Figure 6.11 graphically represents the responses related to the “Satisfaction” 
category. The weighted percentage scores per stakeholder group and the average 
weighted percentage score are detailed in Table 6.15. 
Table 6.15: Mean weighted scores per stakeholder group for the satisfaction category (expressed as a 
percentage) 
Parents Doctors Nurses School admin Average weighted percentage 
85% 78% 86% 83% 83% 
The average weighted percentage score for this category was 83%. The average 
weighted percentage score was converted from a weighted average score of 4,20 out 
of 5,00 on the 5-point Likert scale that was used in the questionnaire. This score falls 
within the “Agree” range of the Likert scale. Taking into consideration that the 
“Satisfaction” and “Ease of Learning” categories both had a major proportion of their 
contributions towards Factor 4 (User experience), it is clear that e-Vaccination offered 
an overall good user experience and that stakeholders were satisfied with the system.  
6.7 DISCUSSION PERTAINING TO DESIGN AND VISUAL AIDS 
The five questions from the “Design and Visual Aids” category were combined to form 
composite values (calculated as the mean score) to aid in understanding the overall 
perception of this category.  
A Cronbach alpha was used to determine the reliability of the data collected for this 
category. A score of 0,67 was obtained and based on the Cronbach alpha scores and 
ratings presented in Table 3.5, this score has a rating of “questionable” (>0,6 alpha 
<=0,7). It is nonetheless still above the recommended minimum of 0,65. This score 
showed that data that was collected from the questionnaire was reliable and could 
further be analysed.  
A Chi-Square test was used to determine if the responses provided by the participants 
were random or were related to a variable, being the participants’ perceptions of the 
design and visual aids in e-Vaccination. The related null hypothesis and alternate 
hypothesis are presented below: 
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H0- design and visual 
aids Chi-Square 
The proportions of scores for 
the design and visual aids 
category are the same 
between the observed and 
the expected responses 
H1- design and visual 
aids Chi-Square 
At least 2 proportions of scores 
for the design and visual aids 
category are different between 
the observed and the expected 
responses 
The results of the Chi-Square test have been summarised in Table 5.18 which has 
been reproduced below. 
Table 5.18: Chi-Square results table for the design and visual aids category data  
Chi-Square value† 169,20 
Df 4 
Critical Chi-Square value based on the Chi-Square f 
table‡ 
9,49 
Approximate p value based on the Chi-Square f table <0,001 
Level of significance (Alpha level) 0,05 
Outcome of Chi-Square calculation 169,20† > 9,49‡ 
Result H0- design and visual aids Chi-Square Rejected 
† Chi-Square value 
‡ Critical Chi-Square value based on the Chi-Square f table 
The results of the Chi-Square test showed that data that was collected from the 
questionnaire for the “Design and Visual Aids” category was not random. 
Once it was determined that the data collected for this category was reliable and not 
random, the ANOVA test was run. The subsequent ANOVA test results was used to 
determine if the variances in the responses between the 4 stakeholder groups was 
statistically significant for the design and visual aids category. The related null 
hypothesis and alternate hypothesis are presented below. 








H0- design and visual 
aids ANOVA 
The mean scores for the 
design and visual aids category 
across the 4 stakeholder 
groups are the same 
H1- design and visual 
aids ANOVA 
At least 2 mean scores for the 
design and visual aids category 
across the 4 stakeholder 
groups are different 
Table 5.20 reproduced below is a summary of the ANOVA calculations for the design 
and visual aids category. 
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Table 5.20: Results of the ANOVA calculation for the design and visual aids category 
Sample size 118 
Cronbach alpha 0,67 
Level of significance (Alpha value) § 0,05 
df between groups † 3 
df within groups ‡ 114 
F value 1,45 
p value ¦ 0,23 
f crit 2,68 
Outcome of calculation 0,23¦ > 0,05 § 
Result H0- design and visual aids ANOVA Accepted 
§ Level of significance (Alpha value) 
† df between groups 
‡ df within groups 
¦ p value 
The result of the ANOVA test shows that the mean scores between the stakeholder 
groups for the design and visual aids category were not statistically different. This 
meant that the four stakeholder groups shared common perceptions towards the 
design and visual aids of e-Vaccination. 
A PCA was then run on the composite values of the “Design and Visual Aids” category. 
From this, five factors were identified. The percentage contributions of the “Design and 
Visual Aids” category towards the five factors identified by the PCA are depicted in 
Figure 6.12. 
 
Figure 6.12: The percentage contributions of the design and visual aids category towards the five 
factors identified by the PCA  
The PCA test showed that this category contributed 74,2% to Factor 2 that was 
labelled in Section 6.2.4 as “Graphical design”. It was noted in Chapter 5 that a 
question from this category was worded in a negative way. This could have resulted 
in some of the respondents being unsure of which option to select with regards to their 
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perceptions towards the use of graphical images in the menu versus written 
instructions. Based on the results of the ANOVA test and the overall weighted 
percentage score of 78% for this category it is inferred that the stakeholders were in 
favour of the use of images or icons as a primary means to navigate through the 
system and that text was a secondary means. The use of a graphical interface could 
have saved the stakeholders’ time while navigating to the required function without 
having to read the text below it. The large icons could have also made clicking or 
tapping on the required feature easier when using a desktop or smartphone. 
Figure 6.13 is a graphical representation of the overall mean weighted scores 
(expressed as a percentage) for this category. 
 
Figure 6.13: Mean weighted scores (expressed as a percentage) amongst the four stakeholder groups 
for the design and visual aids category 
Figure 6.13 graphically represents the responses related to the “Design and Visual 
Aids” category. The weighted percentage scores per stakeholder group and the 
average weighted percentage score are detailed in Table 6.18. 
Table 6.18: Mean weighted scores per stakeholder group for the design and visual aids category 
(expressed as a percentage) 
Parents Doctors Nurses School admin Average weighted percentage 
80% 75% 83% 75% 78% 
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The average weighted percentage score for this category was 78%. The average 
weighted percentage score was converted from a weighted average score of 3,96 out 
of 5,00 on the 5-point Likert scale that was used in the questionnaire. This score falls 
within the “Agree” range of the Likert scale. Based on the statistical analysis and mean 
scores per stakeholder group as well as the overall scores, it is evident that the 
stakeholders are in favour of this type of graphical user interface (utilising large icons) 
for this type of application. The stakeholders were therefore in favour of the design 
and visual aids of e-Vaccination. 
6.8 COMPARISON BETWEEN THE STAKEHOLDER GROUPS 
The average weighted scores (expressed as a percentage) for the different 
stakeholders across the five categories was above 83%. Figure 6.14 is an illustration 
of the average weighted scores (expressed as a percentage) for the four stakeholder 
groups for all five categories. 
 
Figure 6.14: An overlay of the average weighted scores (expressed as a percentage) for the four 
stakeholder groups for all five categories  
 
Figure 6.15 is a bar chart that shows the comparison of the average weighted scores 
(expressed as a percentage) for all the categories across all the stakeholders. 
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Figure 6.15: Combined bar chart of the stakeholders’ average weighted scores (expressed as a 
percentage) per category 
Figure 6.15 shows that the “Design and Visual Aids” category had a lower score 
amongst the stakeholders. As mentioned earlier, this could be due to a question being 
negatively worded. The “Usefulness” category showed the highest score at 90% whilst 
the lowest score of 75% was observed for the “Design and Visual Aids”. 
Figure 6.16 contains a detailed breakdown of the average weighted scores 
(expressed as a percentage) for all five categories. 
 
Figure 6.16: Average weighted scores (expressed as a percentage) of the stakeholders per category 
Based on the Figures 6.14 – 6.16, the stakeholders’ scores are ranked as follows: 
1. Nurses (85%); 
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2. Parents (84%); 
3. School administrators (83%); and 
4. Doctors (79%). 
As mentioned in Section 3.3, another study showed that doctors showed the least 
support for an information system that shared patient information with other hospitals. 
This study shows doctors (ranked 4th) also had the lowest scores. 
6.9 COMMENTS RECEIVED FROM THE STAKEHOLDERS 
During some engagement with the stakeholders, many positive comments were 
received regarding e-Vaccination. Many of the stakeholders seemed pleased with the 
idea of a digital record for vaccination storage. The stakeholders also enjoyed using 
e-Vaccination and did not seem to require assistance with it. The comments received 
from the stakeholders are captured at the end of Chapter 7 (Figure 7.2). 
6.10 ANSWERING THE RESEARCH QUESTION 
The research question, “What are the perceptions of the key stakeholders towards 
replacing the paper-based vaccination card with an electronic vaccination record 
system?” can now be answered.  
Based on the results of the statistical analysis, it is evident that the four key 
stakeholder groups share a common perception towards the use of a digital storage 
mechanism for vaccination records. The high weighted scores of approximately four 
out of five for all five categories matches the “Agree” option in the Likert-scale. The 
stakeholders therefore agree that e-Vaccination is useful, easy to use, easy to learn, 
satisfying to use and contains good design and visual aids. The four stakeholder 
groups are therefore in favour of replacing the current paper-based vaccination card 
with an electronic vaccination record system. 
6.11 SUMMARY OF DISCUSSION OF RESULTS 
The eHealth maturity model for developing countries and the steps identified by the 
Department of Health to move South Africa into Stages 4 and 5 of the model were 
discussed in-depth in Chapters 2 and 4. To recap, The Department of Health has 
identified the steps as summarised in Figure 2.24, which has been reproduced below.  
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Figure 2.24: The 6 steps identified by the Department of Health to take South Africa into stages 4 and 
5 in terms of eHealth (Department of Telecommunications and Postal Services, 2017) 
Steps 1, 2, 3, 4 and 6 of those steps can be associated with the practicality of a health 
information system.  
It is noted that the PCA revealed five underlying factors, one of which was practicality. 
In addition, the average weighted percentage score for the “Usefulness” category 
(practicality) was 87% which, together with the H0- usefulness ANOVA being accepted, 
highlights that stakeholders supported a digital vaccination records management 
system that is practical. We can therefore deduce that a digital vaccination records 
management system must be designed with these practical features in mind, in order 
to support both the Department of Health’s steps to move South Africa into Stages 4 
and 5 of the eHealth maturity model as well as stakeholder acceptance of such a 
system. Being able to move South Africa into the higher stages of eHealth maturity 
can benefit the overall healthcare system. 
The PCA revealed five underlying factors relating to the digitisation of vaccination 
records. These were user friendliness, graphical design, practicality, user experience 
and usability. These five important factors will have an influence on the successful 
implementation of a digital vaccination records management system. The designers 
and implementers of such a system would need to pay special attention to the 
graphical design of the system, as this has an impact on how stakeholders interact 
with the system. In addition, there needs to be adequate and relevant functionality 
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within the system to ensure that the system is of practical use to stakeholders. 
Incorporation of these factors would therefore promote a positive user experience, 
contributing to the usability of the system.  
While the above provided useful information for any future development of digital 
vaccination records management systems, it was not sufficient to answer the research 
question. To answer the research question, a statistical analysis needed to be 
performed.  
An analysis of the weighted scores shows an average score of 4 out of 5 for all five 
categories contained in the questionnaire, which were usefulness, ease of use, ease 
of learning, satisfaction and design and visual aids. This translated to the “Agree” 
option from the Likert scale. The stakeholders therefore agreed that e-Vaccination was 
useful, easy to use and easy to learn. The stakeholders are also satisfied with e-
Vaccination and found the design and visual aids useful. This result is further 
supported by the outcome of the ANOVA test, which showed that the four stakeholder 
groups shared common perceptions for all five categories. 
The next chapter (Conclusions and recommendations), will present the conclusions of 
this research together with future recommendations. The research process will also 
be reflected upon.  
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CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS 
 
Figure 7.1: Structure of Chapter 7 
7.1 INTRODUCTION 
In the previous chapter, the results of the statistical analysis were discussed. The 
research question was answered in relation to the five hypotheses created from the 
research instrument as well as the stakeholders’ perceptions towards vaccination 
storage in Gauteng. In this chapter, the conclusions of the study will be discussed 
together with the recommendations and suggestions for further research.  
7.2 CONCLUSIONS OF THE STUDY 
The results of this study show that the key stakeholders support the development of a 
digital system for the safe and secure storage of vaccination records in Gauteng. 
Countries are moving towards EHR for citizens (Kleynhans, 2011). An electronic 
vaccination record system in Gauteng would support this trend. A digital system of this 
nature also supports the Department of Health’s aims to move South Africa from Stage 
3 to Stage 4 & 5 of the eHealth maturity model for developing countries (Department 
of Telecommunications and Postal Services, 2017). Having access to real-time 
information as discussed in Chapter 6 could also bring in new dimensions to what is 
possible during outbreaks. 
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These conclusions are based on the data that was received and analysed in a 
quantitative manner. In addition to this, there was information of a qualitative nature 
collected indirectly. These were comments from the stakeholders. There were nurses 
who asked, “When will the system be ready to use?” Some parents commented, “I 
thought this was already done.” There were doctors who said, “There are cases when 
I need vaccination records, but we don’t have access to them. This will help.” 
The commencement of this research in 2017 coincided with a Measles outbreak in 
Gauteng and other parts of the World (WHO, 2018). Towards the tail end of this 
research in 2020, the Coronavirus disease (COVID-19) pandemic swept across the 
globe (WHO, 2020). Pandemics such as this can and have occurred without warning. 
Knowing whether patients are immunised against these diseases can help determine 
how at risk patients are to the disease. Reliable, accessible, accurate and real-time 
vaccination records can play a crucial role. Having more data points such as 
vaccination information at the fingertips of policy makers could reduce mortality rates. 
7.3 RECOMMENDATIONS 
Vaccination records for minors form one subset of information needed for an EHR for 
every citizen. The foundations of an EHR should be laid first, followed by data subsets 
such as vaccination records. In 2011, the South African environment was not ready 
for a national electronic health record (Kleynhans, 2011). A re-evaluation of the South 
African environment could be conducted to determine if now, in 2020, the South 
African environment can support an electronic health record. Once this has been 
established, data subsets such as vaccination records can be included in the overall 
design of the electronic health record for all South Africans.  
7.4 SUGGESTIONS FOR FURTHER RESEARCH 
This study focuses on the mandatory and optional vaccinations required by the South 
African Department of Health for minors. Future research could include one or more 
of the following aspects: 
• Travel vaccinations – When visiting certain countries, individuals might be 
required to have vaccines to limit their risk to vaccine preventable disease 
which might exist in that area (Netcare, 2016), 
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• Cross-border access to vaccination information – Allowing different countries 
to access South Africa’s vaccination records when gaining entrance into their 
country in the event of the physical vaccination card not being present, 
• A more in-depth analysis could be performed on other underlying factors not 
highlighted in this research which could affect the implementation of a digital 
vaccination records management system, 
• The effect of a digitised system on the supplying and distribution of vaccines to 
clinics based on the demand and availability of vaccines, 
• This research could be extended to include vaccinations for adults with an 
emphasis on vaccinations relating to pandemics. 
This research was conducted for Gauteng (provincial level). Research could be 
conducted at a national level to determine the perceptions of the key stakeholders 
across all the provinces in South Africa. 
7.5 REFLECTIONS ON THE RESEARCH 
In this section I discuss my reflections on this research. The scientific reflection 
describes how I grew as a researcher from a scientific perspective. This includes how 
I looked at and analysed the relevant data. The methodological reflection highlights 
some of the challenges that I experienced and what I would have done differently. My 
substantive reflection emphasises my thoughts on the importance of electronic 
medical records. In the personal reflection, I discuss how the idea of this research 
originated as well as some of the highlights that I experienced during this research. 
7.5.1 SCIENTIFIC REFLECTION 
During the course of this research, I expanded my scientific knowledge immensely. I 
gained an understanding of how to conduct a literature review, utilising a systematic 
approach, how to filter the research that I had collected and analyse it in accordance 
with the aims of my research. I became proficient in the various ways that data could 
be collected, how to determine which collection approach should be used based on 
the type of research, the requirements that I would need to comply with in order to 
gather information from the general public, and how to perform a statistical analysis of 
the data once collected. Crafting this research and evaluating the results of the 
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different aspects has led me to think and analyse in new and different ways, which I 
am profoundly grateful for. 
7.5.2 METHODOLOGICAL REFLECTION 
A project of this nature, which took over 3 years to complete, had challenges as well. 
The university’s ethical clearance process took longer than expected due to the 
perception that patient’s medical records were being accessed and shared by the 
stakeholders. This however was untrue, as the vaccination records on the system 
were randomly created. Looking back at the clearance process, I would have made 
the patient data aspect clearer. I would have shared examples of the random data that 
was created, proving that no real information was being shared. During the second leg 
of the ethical clearance process, there were also delays from the Gauteng Department 
of Health. These delays resulted in the research taking almost a year longer than it 
should have.  
The first round of statistical analysis showed a summary of the outcomes but did not 
emphasize the details of each technique. The statistical analysis was then reformatted 
to include more details of the analysis. Careful consideration was made to avoid “p 
hacking” which includes changing the data analysis techniques in a way that makes 
the data show that the claims are supported (Cumming, 2016). This concept was 
based on the research by Ioannidis (2005). 
7.5.3 SUBSTANTIVE REFLECTION 
The literature review shows that countries are moving towards the use of electronic 
medical records for their citizens. Perhaps not every sub-set of medical records needs 
to be available to the government and all health practitioners. In the case of 
vaccination records however, the need for efficient access to this type of information 
is vital especially during epidemics and pandemics such as the Coronavirus disease 
(COVID-19).  
This research has shown that electronic health records are in use in globally. Even 
though some health practitioners have shown lower support for such systems (Wang 
et al., 2015), once digital records are securely stored, they can be accessed easier 
than paper-based records in cases where time is limited. When national decisions 
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need to be made, having access to accurate and up to date information will make a 
difference. 
7.5.4 PERSONAL REFLECTION 
As I reflected on the research, I thought back to how the seed for this topic was 
planted. In 2014, I became a father and witnessed the first vaccinations being 
administered to my daughter. Once the nurse was done, the vaccination card was 
updated and handed to me. I was told to keep the card very safe. Being an Information 
Systems professional holding an Honours degree in Computer Science, I decided to 
embark on a mission to determine how to digitise the vaccination card.  
When I approached UNISA in 2016, Professor Singh who was familiar with the 
electronic government systems as well as electronic medical systems was open to the 
idea. In 2017 my research proposal was accepted and in 2018, I started this 
dissertation.  
During the course of this research I had the opportunity to speak to some of the key 
stakeholders in person. This gave me a feel for their perceptions towards 
e-Vaccination. Many of the stakeholders were visibly excited about the research and 
praised the idea. They hoped to see a digital vaccination record management system 
implemented not only for Gauteng but for the whole of South Africa. Some of the 
comments I received are displayed in Figure 7.2.  
 
Figure 7.2: Comments received from some of the stakeholders with respect to e-Vaccination and this 
research  
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Receiving these positive comments made me feel like this research could have a 
major impact on the identified stakeholders as well as the eHealth aims of South 
Africa. These comments also lifted my spirits during those moments when the 
research challenged me.  
The opportunity to publish a conference proceeding article and to present my research 
at conferences such as the IEEE and the Ekurhuleni Annual Health Research 
Conference (where I received the award for the best research poster) are cherished 
experiences. I met other researchers who had similar interests, with a drive to improve 
eHealth in South Africa and the rest of Africa. I still correspond with these researchers 
and hope that in the future we may collaborate on projects or research that will take 
us further in our aims. 
It is my sincere hope that this research makes material impact on those policy makers 
who have the ability to implement such a system, so that we can see e-Vaccination, 
and the consequential benefits thereof, come to fruition in the near future. 
Figure 7.3 is a summary of this research from idea to conclusion. 
 
Figure 7.3: A summary of this research from idea to conclusion   
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This research study may be understood as a platform for ongoing research. The 
findings from this research offer opportunities for others to follow on and further 
improve on these understandings. In the words of Checkland (1999), writing about 
systems thinking and practice: 
"Obviously the work is not finished, and can never be finished. There are no absolute 
positions to be reached in the attempt by men to understand the world in which they 
find themselves: new experience may in the future refute present conjectures. So the 
work itself must be regarded as an on-going system of a particular kind: A learning 
system which will continue to develop ideas, to test them out in practice, and to learn 
from the experience gained." 
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7. GAUTENG SCHOOLS VACCINATION RECORD REQUIREMENTS (RANDOM 
SAMPLE OF 24) 
Name of 
School 





Vaccination card not 



















Copy of vaccination card 









Scanned copy of 
Vaccination card 







Certified copy of 
vaccination card upon 









Vaccination card not 











Vaccination card not 







Dynamo Kidz Vaccination card not 










Vaccination card not 





















Vaccination card not 











Copy of vaccination 









Vaccination card not 





















Vaccination card not 
















Vaccination card not 










Vaccination card not 







Vaccination card not 










Vaccination card not 












Vaccination card not 



















Copy of vaccination card 



















8. IMAGE OF MEASLES RASH IN A CHILD 
 
The skin reaction that results from contracting the Measles virus, (Health24, 2018). 
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9. MEASLES 2ND DOSAGE COVERAGE IN GAUTENG FROM 2015 TO 2017 
Province District 2015 / 2016 2016 / 2017 
Coverage % Coverage % 
Gauteng Ekurhuleni 95,8 124,8 
Gauteng Johannesburg 91,5 102,7 
Gauteng Sedibeng 104,9 129,2 
Gauteng Tshwane 83,4 84,1 
Gauteng West Rand 101,8 114,4 
Measles (2nd dosage) in South Africa by district from 2015 / 2016 to 2016 / 2017, 








My name is Wesley Moonsamy. I am a MSc. student at the University of South Africa 
(UNISA). My research topic is: An investigation into electronic vaccination cards for 
minors in Gauteng. This questionnaire will assist me in gaining more insight regarding 
the current paper-based vaccination record and the proposed electronic vaccination 
card. 
You have been identified as a key stakeholder in determining whether an 
electronic-based vaccination storage system is preferred to the current paper-based 
vaccination card. 
Please take note of the following: 
• The completion of this questionnaire is voluntary and is entirely up to you. You 
may stop filling in this questionnaire at any time. 
• All responses to this questionnaire will be treated in a confidential manner. 
• Your responses will remain anonymous. Please do not insert any information 
on this questionnaire which could lead to you being personally identified. 




Wesley Moonsamy (Researcher) – 41179609@mylife.unisa.ac.za  
Dr Shawren Singh (Supervisor) – singhs@unisa.ac.za 
The questionnaire should take approximately 20 minutes to complete. 
Please indicate all answers with a tick (“ü”) in the appropriate box. 
Please select only 1 answer per question. 
 
SECTION A: Respondent information (Demographics) 
1. Regarding this questionnaire, please select your primary role: 
 193 
Medical Doctor  Parent  
Nurse  School Administration Staff  
 
For the following questions, please tick the appropriate box Yes No 
2. Do you work in Gauteng, South Africa?   
3. Do you have access to a smartphone?   
4. Do you have access to the Internet?   
5. Do you have an e-mail address?   
 
SECTION B: Vaccination records in Gauteng, South Africa 
1. In your experience with vaccinations, how is a child’s vaccination records 
primarily stored? 
Paper-based vaccination card  No records are kept  
Electronic systems  Not sure  
 
2. Paper-based vaccination cards can be susceptible to loss or damage. Are you 
aware of a vaccination card that has been lost? 
Yes  No  
 
3. If your answer to the question above was “Yes”, please select the measures taken 
to recover the lost vaccination records. If your answer was “No”, please select “Not 
applicable”. 
Successfully obtained vaccination records from the vaccination clinic  
Performed a blood analysis on the child to determine the vaccines that were administered  




Not applicable  
 
4. In your opinion, who should be responsible for ensuring that a child’s vaccination 
records are safely stored? 
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Parents / Guardians  Government  
























































5. Children living in Gauteng receive their vaccinations 
on time 
     
6. Paper-based vaccination cards are a reliable way to 
store a child’s vaccination records 
     
 
SECTION C: A centralised electronic vaccination record system in Gauteng, 
South Africa managed by the Government 
Based on the prototype system (E-vaccination application) that you have used, please 

























































1. The E-vaccination application can help me to be 
more effective when handling vaccination records 
     
2. The E-vaccination application can help me to be 
more productive when using the vaccination functions 
     
3. The E-vaccination application is useful for 
managing vaccination records 
     
4. The E-vaccination application will save me time 
when storing vaccination records 
     
5. The E-vaccination application will save me time 
when accessing vaccination records 
     
6. The E-vaccination application meets my needs in 
terms of storing vaccination records 
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7. The E-vaccination application meets my needs in 
terms of retrieving vaccination records 
     
8. The E-vaccination application saves my inputs as 
required 
     
9. The E-vaccination application displays vaccination 
records in a way that I can understand 
     
Ease of use 
10. The E-vaccination application is easy to use      
11. The E-vaccination application is not a complicated 
system to use 
     
12. The E-vaccination application is user friendly as it 
minimises the amount of input I need to enter 
     
13. Any action on the E-vaccination application is 
completed with the minimum number of possible steps 
     
14. Using the E-vaccination application is effortless      
15. I can use the E-vaccination application without 
written instructions 
     
16. There are no inconsistencies within the E-
vaccination application 
     
17. I can recover from mistakes easily when using the 
E-vaccination application 
     
18. I can use the E-vaccination application 
successfully every time 
     
Ease of Learning 
19. I quickly understood how to use the E-vaccination 
application 
     
20. I easily remember how to use the E-vaccination 
application 
     
21. I quickly became skilful with the E-vaccination 
application 
     
22. I quickly learned how to navigate through the E-
vaccination application 
     
23. I quickly learned what the colour coding of the 
visual aids (icons) meant 
     
Satisfaction 
24. I am satisfied with the E-vaccination application      
25. I would recommend the E-vaccination application 
to a friend 
     
26. The E-vaccination application works the way I 
want it to work 
     
27. I am satisfied with the overall appearance of the E-
vaccination application 
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28. I am satisfied with how the navigation of the E-
vaccination application works 
     
Design and Visual Aids 
29. The use of visual aids (icons) are helpful when 
using the E-vaccination application 
     
30. I would prefer written instructions on the E-
vaccination application instead of visual aids (icons) 
     
31. The visual aids (icons) help me navigate the E-
vaccination application easily 
     
32. The colour coding of the visual aids (icons) helps 
me to determine what the link means 
     
33. The vaccination statistics provided are useful      
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11. KMO VALUES 


































KMO (Overall) 0,91 
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12. EIGENVALUES FOR THE 33 QUESTIONS 
Component Eigenvalue Variability (%) Cumulative % 
1 16,93 51,30 51,30 
2 2,05 6,22 57,52 
3 1,78 5,38 62,91 
4 1,38 4,19 67,10 
5 1,22 3,69 70,79 
6 1,05 3,19 73,98 
7 0,85 2,57 76,55 
8 0,76 2,29 78,84 
9 0,71 2,16 80,99 
10 0,64 1,94 82,93 
11 0,60 1,81 84,75 
12 0,55 1,65 86,40 
13 0,49 1,47 87,87 
14 0,43 1,30 89,18 
15 0,40 1,21 90,39 
16 0,37 1,11 91,50 
17 0,34 1,04 92,54 
18 0,31 0,95 93,49 
19 0,28 0,84 94,33 
20 0,25 0,77 95,10 
21 0,22 0,67 95,78 
22 0,21 0,63 96,40 
23 0,18 0,56 96,96 
24 0,16 0,48 97,45 
25 0,14 0,43 97,87 
26 0,13 0,39 98,26 
27 0,12 0,35 98,61 
28 0,11 0,34 98,95 
29 0,10 0,29 99,25 
30 0,08 0,25 99,50 
31 0,07 0,20 99,70 
32 0,05 0,17 99,87 
33 0,04 0,13 100,00 
 




14. FACTOR LOADINGS FOR THE 5 COMPOSITE CATEGORIES 
 Category F1 F2 F3 F4 F5 
Usefulness 0,806 -0,320 -0,486 0,101 0,035 
Ease of Use 0,905 0,001 0,191 -0,103 0,367 
Ease of Learning 0,864 -0,037 0,266 0,408 -0,126 
Satisfaction 0,868 -0,218 0,135 -0,354 -0,233 
Design and Visual Aids 0,725 0,661 -0,176 -0,045 -0,067 
 
